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Production and consumption of xenobiotic organic compounds have increased in 
recent years (36). Xenobiotic compounds are chemicals which are foreign to the 
biosphere. Xenobiotics have structural groups which are not found in natural pro-
ducts. Over five million chemical compounds are now known and industry produces 
about 150 million tons of chemicals annually (54). Release into the environment has 
resulted from increased production and consumption of xenobiotics. 
Xenobiotics become pollutants when they exert an undesirable effect. The release 
of large quantities of these compounds has caused major pollution problems and 
health hazards (24). Release directly from industry and agriculture is responsible for 
considerable contamination of soil and water in the United States. Contamination of 
soils and aquifers is a growing concern. Nearly half the United States population 
depends on ground water for potable water (100). These concerns have resulted in the 
need for quick and efficient cleanup process to be developed. 
Compounds that cause contamination include herbicides, pesticides, degreasers, 
plastics, and solvents (25). Although many xenobiotics are recalcitrant, microbes have 
evolved systems to degrade a wide range of xenobiotics. The xenobiotics metabolized 
are aromatic and aliphatic organics, including halogenated forms. Chlorinated 
aromatic compounds are major environmental pollutants because they are often 
released in substational quantities, are toxic, are resistant to degradation, and 
accumulate in sediment and biota. Some xenobiotics can be mineralized by bacteria, 
fungi, or diverse microbial populations working as consortia (2). 
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Microbial degradation depends on environmental factors such as temperature, 
pH, oxygen, salinity, and availability of other nutrients. Important molecular 
properties include water-solubility, lipid water partition coefficient, volatility and also 
molecular size, charge, shape and presence of functional groups. All naturally 
occurring compounds can be utilized by a microorganism under suitable conditions 
(67), but many of the xenobiotic compounds that are able to be mineralized have been 
in the environment less than 50 years. Many of these compounds have no known 
natural analogs. While organisms not previously exposed to xenobiotics cannot be 
expected to have the ability to reduce them, relatively common bacteria have been 
observed to degrade xenobiotic compounds (5). Some researchers believe that given 
the proper conditions, microbes are capable of degrading any compound (100). 
Microorganisms have shown an ability to metabolize a wide array of xenobiotic 
compounds once exposure has occurred. Although some xeno biotics can be 
metabolized, many are resistant to microbial attack (67). A problem in the degradation 
of some alkanes and cycloalkanes as well as other compounds is the toxicity of the 
substrate compound to the organism. Persistence of compounds is often linked to the 
presence of chemical substituents, including amines, methoxy groups, sulfonates, nitro · 
groups, substituted benzene rings, ether linkages, and branched carbon chains. The 
presence of halogenated substituents in alkyl and aryl compounds, particularly the 
chlorinated moieties present in solvents, pesticides, plasticizers, and the trihalo-
methanes are important in the persistence of compounds. Metabolites such as 
chlorocatechols or chlorosubstituted ring fusion products may inhibit growth and may 
also suppress development of the marginal microbial community that utilize 
haloaromatics (100). 
The ability of microorganisms to metabolize xenobiotic compounds, once 
exposure has occurred, is poorly understood at the molecular level. The TOL plasmid, 
which is self-transmissible and contains two or more operons, encodes enzymes 
required for the degradation of methylbenzenes, such as toluene, xylenes, and 1,2,4-
trimethylbenzene, via methylbenzoates (4). The TOL plasmid is naturally occurring. 
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This suggests that the evolution of the ability to degrade xenobiotic compounds may 
have resulted, in part, from the interaction with molecules produced by indigenous 
microbes (66). It has been shown that indigenous organisms at a pristine site could 
readily adapt to degrade xenobiotic compounds to which they were never previously 
exposed (112). A wide variety of microorganisms from aquatic and soil biota have 
demonstrated the ability to adapt once exposed to xenobiotics, including members 
from the genera Arthrobacter, Acinetobacter, Alcaligenes, Bacillus, Corynebacterium, Flavo-
bacterium, and Pseudomonas. 
Microorganisms' ability to metabolize a wide variety of xenobiotics has made 
them valuable in biodegradation. Microbiological-based techniques for the destruction 
of naturally occurring organic compounds have historically been the treatment of 
choice, relative to physical or chemical methods (66). The ability of microorganisms to 
remove xenobiotics from the environment has resulted in research to elucidate the 
mechanisms of metabolism. Understanding the pathways may allow for the 
construction of novel pathways to metabolize xenobiotic compounds that are presently 
thought to be recalcitrant. Modifications to increase the range of capabilities of the 
microbes as well as the rate of degradation and survival stability of the organism 
under environmental stresses have been attempted. Excellent results have been 
obtained in laboratory situations (66). Abramawicz (1) combined genetic material from 
26 different isolates to produce a single useful bacterium. The isolate demonstrated the 
ability to metabolize PCBs. The first organism designed for use in the field was an oil-
degrading bacterium developed by Chakrabarty (66). 
Molecular studies have produced information on a variety of pathways that are 
involved in the metabolism of xenobiotic compounds. A modified ortho cleavage 
pathway has been shown to be responsible for the biodegradation of a large array of 
chloroaromatic compounds. A well characterized group of modified ortho cleavage 
pathway operons that encode functions for the metabolism of catechol and 
chlorocatechols provides a model sytem for studying the regulation of evolutionarily 
related pathways. These include operons in degradative pathways for 3-chlorobenzoic 
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degradative pathways for 3-chlorobenzoic acid from Pseudomonas putida, 1,2,4-
trichlorobenzene from a Pseudomonas sp., 2,4-dichlorophenoxyacetic acid (TFD) from 
Alcaligenes eutrophus, and benzoic acid from P. putida and Acinetobacer calcoaceticus (26). 
Studies on the regulatory mechanisms of biodegradative pathways have not 
provided a complete understanding of regulation. In order to genetically manipulate 
degradative pathways the regulation of the pathways must be completely understood. 
An aspect of regulation not well understood is the inducer of the chloroaromatic 
pathways. An interaction between inducer and activator results in increased trans-
criptional activation of the pathway. The inducing agent and the interaction are not 
understood. Understanding these aspects is important in developing a full under-
standing of the expression characteristics of the pathway. 
Purpose of the Research 
The overall goal of this research is to develop a better understanding of the factors 
involved in the expression of genes involved in the metabolism of a chlorinated 
aromatic compound. This study requires identifying a method to study the expression 
of the structural genes in the TFD pathway of the plasmid pJP4. The plasmid pJP4 was 
isolated from Alcaligenes eutrophus JMP134. The plasmid is a broad host range, 
conjugative, 80 kb plasmid. The plasmid encodes for the degradation of 2,4-
dichlorophenoxyacetic acid (TFD) and 3-chlorobenzoate (3CBA). Expression studies 
and sequence analysis will determine the inducing agent of the pathway. Under-
standing the regulatory mechanisms that are studied will be useful in the construction 
of improved bacterial strains. Such genetically engineered microorganisms could have 
enhanced degradative abilities and broader substrate utilization potentials. These 
microorganisms will be useful in bioremediation processes. 
Goals and Strategies of Research 
Specific goals and strategies for the accomplishment of this research are as follows: 
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1. Identify a system that allows the reliable production of gene fusions. Three 
separate transposon systems will be utilized for the production of lacZ gene fusions in 
the plasmid pJP4. 
2. Use the lacZ gene fusions produced to estimate expression levels of the 
structural genes in the TFD pathway of the plasmid pJP4. The lacZ gene fusions that 
are produced by transposon mutagenesis will allow expression studies to be per-
formed under induced and noninduced conditions. 
3. Determine the inducing agent of the TFD pathway. From the expression 
studies that are performed and DNA sequence analysis, the inducing agent of the 
pathway will be able to be determined. 
CHAPTER II 
LITERATURE REVIEW 
Halogenated Organic Compounds 
Many xenobiotics that have been introduced into the environment are halo-
genated. This halogenation is often implicated as a possible reason for persistence (75). 
Chlorinated compounds have been the most extensively studied of the halogenated 
compounds. Chlorinated hydrocarbons that are degraded by microorganisms are 
grouped into three classes: (i) aliphatic, (ii) polycyclic, and (iii) aromatic (25). 
Chlorinated compounds serve as the basis for most of the information available on the 
biotransformation of xenobiotics. Most of this information has been produced from 
aerobic studies, since aerobic culture techniques are simple compared with anaerobic. 
Some chlorinated aromatics that have been demonstrated to be metabolized by soil 
and aquatic microorganisms are listed in Table 1. 
Pathways for the Degradation of Chlorinated Aromatics 
The basic strategies for the metabolism of aromatic compounds have been 
described. Five phases can be distinguished: (a) entry into the cell-this will usually 
occur by diffusion, but transport mechanisms exist for some compounds (102); (b) 
manipulations of the side-chains and formation of substrates for ring-cleavage; (c) ring-
clea vage; (d) conversion of the products of ring-cleavage into amphibolic inter-
mediates; and (e) utilization of the amphibolic intermediates (36). 
A variety of different pathways have been described in detail for degradation of 
chlorinated aromatics. The crucial point in degradation is removal of halogen substi- · 




BIODEGRADATION OF SOME CHLORINATED 
AROMATIC COMPOUNDS 
Compound Microorganism Plasmid Reference 
1,2-Dichlorobenzene Pseudomonas sp. (44) 
1,3-Dichlorobenzene Alcaligenes sp. (28) 
1,4-Dichlorobenzene Alcaligenes sp. (92) 
Pseudomonas sp. (99) 
P. putida + (78) 
2,6-Dichlorotoluene P. cepacia HCV + (109) 
2-Clorobenzoate P. cepacia (115) 
3-Chlorobenzoate A. eutrophus + (23) 
Pseudomonas sp. B13 + (31) 
P. putida + (40) 
4-chlorobenzoate Arthrobacter sp. (69) 
Pseudomonas sp. CBS3 (89) 
A. denitrificans NTB-1 (108) 
4-chlorophenol Pseudomonas sp. (91) 
Alcaligenes sp. + 
4-chlorophenylacetate Pseudomonas sp. CBS3 (62) 
2,4-D A. eutrophus + (80) 
Pseudomonas sp. (59) 
Flavobacterium sp. + (25) 
2,4,5-T P. cepacia (83) 
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pathway with reductive, hydrolytic, or oxygenolytic elimination of the halosubstituent. 
Nonaromatic structures may also be generated, which spontaneously lose halide by 
hydrolysis of hydrogen halide by 13-elimination (84). 
Two well studied pathways that result in cleavage of the aromtic ring are meta 
cleavage of chloroprotocatechuate and the ortho cleavage of halosubstituted catechols 
(84), benzoates, phenols, and phenoxyacetates (12, 32, 34, 35, 61, 103). The metabolism 
of 2,4-dichlorophenoxyacetic acid (TFD) is performed by a modified ortho cleavage. 
The conversion is demonstrated in Figure 1. 
Genetics of Chlorinated Aromatics Degradation 
The genes necessary for the degradation of chlorinated aromatics may be carried 
on plasmids or the chromosome. Most of the genes that encode for degradation of 
chlorinated hydrocarbons are plasmid mediated, such as the 3-chlorobenzoate (3CBA) · 
degrading plasmid pAC25 and the TFD degrading plasmids pJP4 and pRClO (25). 
Table 2 contains the names of various plasmids that are involved in the degradation of 
chlorinated aromatics. The plasmid pJP4 of Alcaligenes eutrophus JMP134, that encodes 
the degradation of TFD, 3CBA, and 2-methyl-4-chlorophenoxyacetic acid (30), was 
used in these studies. 
Expression of Chloroaromatic Degradation Pathways 
Three similar ortho cleavage pathways have been studied in detail. The operons of 
the pathways include clcABD, tcbCDEF, and tfdCDEF. The clcABD operons converts 3-
chlorocatechol to maleylacetic acid. The tcbCDEF encodes for the conversion of 3;4,6-
trichlorocatechol to 2-chloromaleylacetic acid, and 3,5-dichlorocatechol to 2-chloro-
maleylacetic acid (26). Transcription of these pathways has been shown to be · 
controlled by regulatory proteins. The clcABD operon is regulated by ClcR, TcbR 
regulates the tcbCDEF operon, and TfdR has been shown to regulate tfdCDEF (26, 56, 
107). Each of these is a member of the LysR family of bacterial regulators. Other 
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Figure 1. TFD Pathway on the Plasmid p JP4 
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TABLE2 
SOME DESIGNATED PLASMIDS ENCODING DEGRADATION 
OF CHLORINATED HYDROCARBONS 
Molecular 
Plasmid Compound Size Reference 
pUU204 2-Monochloropropionate 53kb (45) 
pKFl 4-Chlorobiphenyl 82kb (38) 
pSS50 4-Chlorobiphenyl 53kb (93) 
pAC21 1,4-Dichlorobiphenyl 65MDa (22) 
pJP4 3-Chlorobenzoate 
2,4-D and MCP A 80kb (31) 
pEML159 2,4-D l (3) 
* 2,4-D 50-100 MDa (82) 
* 2,4,5-T l (41) 
pAC27 3CBA 110kb (23) 
pAC31 3,5-Dichlorobenzoate 105kb (23) 
pRClO 3CBA 
2,4-D and MCPA 45kb (25) 
pU01 Flouroacetate 44MDa (58) 




The members of the LysR family typically exhibit several properties in common. 
These include a well-conserved amino terminus with a helix-tum-helix motif, selected 
conserved residues throughout the protein, and a size generally ranging from 285 to 
315 residues (50). The majority of LysR family member genes are transcribed 
divergently from a gene or operon they control. 
Gel shift analysis of CatR binding to the catBC promoter region has shown that in 
the absence of the inducer, cis, cis-muconate, CatR at relatively low concentrations 
forms complexes with the catBC promoter. When cis, cis-muconate is present in the 
binding reaction, the affinity of CatR for the promot~r region is increased 
approximately 20-fold (79). The Trpl-trpBA interaction favors the formation of a 
second complex when incubated with the inducer indoleglycerol phosphate (20). The 
regulatory gene, nahR, controls the regulation of the napthalene and salicylate operons. 
Induction by nahR requires salicylate for activation (90). 
Many of these LysR family protein members require an inducer for activation. 
The interaction between the regulatory protein and the inducer increases trans-
criptional activation of the operon which the regulator controls. The exact mechanism 
of the interaction and the resulting expression is not completely understood. It has 
. been proposed that·a protein-protein interaction between RNA polymerase and the 
transcriptional activator stabilizes RNA polymerase binding to the promoter region 
(39). Other suggestions are that changes in DNA topology at the -35 region brought 
about by the transcriptional activator-inducer complex allow proper recognition of the 
-35 region by RNA polymerase (111). 
The mechanism of interaction between the regulator and inducer for other LysR 
members is not well understood either. The affinity of NahR for its respective target 
sites was increased only 2-fold by the inducer. This led to the proposal that the role of 
inducer is not to control binding of the activator to its target sites, but rather to induce 
a conformational change in the constitutively bound activator, which results in 
increased transcription from that promoter. Recent experiments using Trpl have 
suggested an alternative possibility. Hydroxyl radical footprinting showed that the 
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inducer causes: (1) extension of Trpl for protection of its target promoter from the -77 
to -52 region down into the -32 region, (2) a 14-fold increase in target site affinity, and 
(3) appearance of an additional higher molecular weight species in gel retardation 
assays. This was interpreted to mean that the inducer causes binding of an additional 
molecule of Trpl adjacent to the one already bound at -77 to -52 resulting in 
transcriptional activation (53). 
Some of the inducing agents of members in the LysR family have been 
determined. The most closely related pathway to the TFD pathway in which the 
inducing agent has been identified is the catBC operon. The CatR protein, which 
regulates the catBC operon, has been shown to have an increased binding affinity for 
the catBC operon in the presence of cis, cis-muconate (79). In the absence of the inducer 
cis, cis-muconate, CatR at low concentrations forms two complexes with the catBC 
promoter. When cis, cis-muconate is present, the affinity of CatR for the promoter 
region is increased approximately 20-fold (79). 
The only inducing agent of any of these pathways that had been demonstrated 
was for the CAT pathway (79). The TFD, TCB, and CLC pathways contain chlorinated 
muconate compounds as intermediate products in the metabolism process. It had been 
speculated that the chlorinated muconate of these pathways is also the inducing agent 
(26, 107). 
Other LysR Indu,cers 
Other LysR family inducing agents have been identified. The LysR family 
member LysB is involved in the regulation of L-cystein synthesis. The inducer of the 
pathway is o-acetylserine. Mutants which lack the ability to make o-acetylserine can 
only be derepressed by the addition of o-acetylserine to the growth medium (79). 
NahR coordinately regulates the expression of the two naphthalene degradation 
operons of plasmid NAH7. NahR is induced by salicylate. OccR regulates the 
transcription of Ti plasmid encoded genes and is induced by octopine (79). Trpl 
regulates the trpBA genes of the tryptophan synthase pathway. Induction is provided 
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by indoleglycerol phosphate. All these regulatory genes are LysR family members in 
which the inducing agent is known (79). 
Of the most closely related LysR family members to TfdR and TfdS, the CatR 
inducer is the only compound that has been determined. Intermediates of these path-
ways include chlorinated muconate compounds. These chlorinated muconates have 
been speculated to be the inducing agents of each pathway. The inducing agent for 
ClcR has been speculated to be 2-chloro-cis,cis-muconate (26). The inducing agent for 
TcbR has been suggested to be 2-chloromuconic acid (108). If these speculations are 
correct, then the chlorinated muconate is an important compound in the regulation of 
these pathways. 
Degradation of TFD by the pJP4 Encoded Pathway 
2,4-Dichlorophenoxyacetate 
The structure of TFD is given in Figure 1. TFD is a chlorinated aromatic 
hydrocarbon that belongs to a group of halogenated phenoxyacetates. C8H6Cl203 is 
the chemical formula and the molecular weight is 221.04. TFD is used as a herbicide to 
control broad leafed plants. TFD acts like a plant growth hormone. The result is 
increased proliferation of the vascular tissues in the plant. The enlarged tissues block 
transport of nutrients and death of the plant occurs. Monocots and narrow leaf plants 
with scattered vascular tissue arrangements escape the blockage effects caused by 
tissue proliferation. 
Degradation of TFD 
TFD is rapidly degraded by soil microorganisms. It has a half life of six weeks in 
soil and is degraded by a modified ortho cleavage pathway (34, 84). TFD is converted 
into 2,4-dichlorophenol and then to 1,2-dichlorocatechol. The 1,2-dichloro-catechol is 
then converted to cis, cis-chloromuconate, which is converted to chloro-maleylacetate. 
Chloromaleylacetate is then converted to chlorosuccinate and acetyl coenzyme A via 
an NADH dependent reduction or to !3-ketoadipate with the consumption of NADH 
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and liberation of chloride (33, 65). All conversions from chloromaleylacetate are 
encoded by the chromosome and not by pJP4 (65). Acetyl coenzyme A and succinate 
are formed from ~-ketoadipate via the conventional ~-ketoadipate pathway and enter 
the TCA cycle. 
Plasmid pTP4 
The plasmid pJP4 was isolated from A. eutrophus strain JMP134 (30). The plasmid 
pJP4 is a broad host range, conjugative, 80 kilobase plasmid and is a member of the Pl 
incompatability group of plasmids. The plasmid encodes resistance to mercuric 
chloride and phenyl mercury! acetate. Plasmid pJP4 also encodes for the degradation 
of TFD and 3CB (30). 
Genes of TFD Pathway 
The modified ortho cleavage pathway genes and enzyme products of plasmid pJP4 
are shown in Figure 1 (31). The restriction maps of pJP4 and the position of TFD genes 
are shown in Figure 2. The genes are arraged into three operons: tfdA, tfdB and 
tfdCDEF. Two regulatory genes have been identified, tfdR and tfdS (47, 56, 57). Copies 
of genes having a similar sequence have been located on pJP4 (40, 70, 81). These genes 
have been named tfdAIT, tfdCI, and tfdDII.. It has also been demonstrated that tfdR and 
tfdS have identical nucleotide sequences (70). 
Regulation of TFD Pathway 
The expression of TFD genes.is controlled by regulatory elements (47, 56, 57). The 
nature of the expression is not well understood. Original studies proposed that Tfd.R 
regulated the expression of tfdA and tfdCDEF operons, and TfdS regulated the 
expression of tfdB operon (47, 56). This regulation would be unusual for LysR family 
regulatory proteins. A characteristic of LysR family member genes is transcription 
divergently from a gene or operon they control. If the previous regulatory pattern 
described is accurate, Tfd.R and TfdS control operons which are not divergently 
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Figure 2. Physical Map of Plasmid of pJP4 and Positions 
of TFD Genes on BamHI Fragments. Arrows 











previously proposed regulatory scheme is not accurate (70). Further studies need to be 
performed to determine the exact mechanism of control for the TFD pathway. A 
suggestion could be that tfdR, tfdS, and tfdX may regulate genes tfdDII, tfdA, and 
tfdCDEF, respectively. Gene tfdB may be regulated by some downstream element as 
proposed by others and .its promoter showed no homology to other tfd promoters. 
This regulatory scheme is more consistent with other LysR family member proteins. 
Gene Fusions With Transposable Elements 
Genetic fusions have provided an important means of analyzing basic biological 
problems. Gene fusions are used for a variety of reasons. To study the regulation of a 
gene or operon; to detect genes which are subject to a particular regulatory signal; to 
study the mechanism of localization of a protein to an intracellular compartment or to 
the extracellular space; to detect and assay a protein which has not been identified or 
for which no assay exists; to detect a gene, the protein product of which is known, but 
for which there is no simple method for localizing or cloning the gene. Transposon 
mutagenesis allows the mutation, identification, and isolation of genes contained 
within large genetic targets, including prokaryotic (87) and eukaryotic genomes (9, 27). 
Gene fusions are used to allow analysis and manipulation of the expression and 
regulation of genes whose functions are unknown or difficult to assay (7, 37). 
In gene fusions, the control sequences of a gene of interest are placed in front of 
the coding sequences of a reporter gene whose product can be assayed. Expression of 
the gene can be monitored by measuring the reporter gene activity whose product can 
be easily assayed. Gene fusions were used to monitor activities of the structural genes 
in the TFD pathway. A reporter gene that has been used under numerous conditions is 
the !>-galactosidase lacZ gene of Escherichia coli . 13-galactosidase is easily and quantita-
tively assayed and is active in a variety of organisms and when contained within 
hybrid proteins (7). Transcriptional and translation fusions can be produced. 
Transcriptional fusions are generated using sequences that contain the lacZ gene 
including its translational initiation signal; expression of a transcription fusion results 
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in the production of wild type ~-galactosidase. In translational fusions, the translation 
initiation and the amino-terminal coding sequences of a gene are linked 5' to the "lacZ 
coding sequences; expression of a translational fusion results in the production of a 
chimeric protein with ~galactosidase activity. 
Transposable elements that contain. lacZ coding sequences combine the techniques 
of transposon mutagensis and the generation of lac gene fusions. With transposons the 
random insertion of lacZ into a variety of DNA sequences can occur. Modified 
transposons containing lacZ have been constructed that allow the production of 
random gene fusions. Tn3 (101), Tn5 (50, 64), and Tn10 (110) are transposons that have 
been manipulated to contain lacZ genes for use in fusions. A short list of transposable 
elements that are used in genetic studies are listed in Table 3. A more extensive list can 
be found in Berg and Howe's Mobile DNA (8). 
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TABLE3 
USEFUL TRANSPOSABLE ELEMENTS 
Designation Marker Size (kb) Reference 
Tn3-Ap,Km amp, kan 11.70 (42) 
Tn3-HoHol amp, 'lac 14.25 (101) 
Tn1721 tet 11.20 (106) 
Tn5-CM cam 3.90 (88) 
Tn5toxi kan, tox 10.50 (76) 
Mini-Tn5 kan 5.00 (29) 
Tn7-lac lacZYA 11.20 (6) 
Mini-Tn10 tet 4.00 (110) 
Mudil amp, 'lac 37.00 (18) 
Mini-Mu-amp amp 6.00 (17) 
Mudll1734 kan, 'lac 9.70 (15) 
CHAPTER ill 
MATERIALS AND METHODS 
Bacterial Strains and Plasmids 
The bacterial strains and plasmids used throughout these experiments are shown 
in Tables 4 and 5. 
Genetic Manipulations 
DNA Isolation Procedures 
Rapid isolation of plasmid DNA was performed by the modified Birnboim-Doly 
alkaline-SOS method (11). A loopful of freshly grown cells was scraped from a plate 
and suspended in 1 ml of phosphate buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 
4.3 mM Na2HP04·7H20, 1.4 mM KH2P04, pH 7.3) and pelleted for 20 seconds in a 
Beckman Microcentrifuge at room temperature. The cell pellet was then suspended in 
100 µl of a solution containing 2 M glucose, 0.5 M EDTA, 1 M Tris-HCl (pH 8.0), and 
0.2% lysozyme. The sample was incubated for 5 minutes at room temperature. The 
mixture was denatured by adding 200 ml alkaline-SOS (0.2 N NaOH and 1% w/v 
SDS), mixed and incubated on ice for 10 minutes. To neutralize the mixture, 150 µl of 
5 M potassium acetate (pH 4.8) was added and the mixture was incubated on ice for 
5 minutes. The mixture was then centrifuged for 2 minutes in a Beckman Micro-
centrifuge. The supernatant was transferred to a fresh microcentrifuge tube and the 
plasmid DNA was precipitated with 800 µl of 100% ethanol by incubating on ice for 5 
minutes. The DNA was pelleted by centrifuging for 2 minutes. The pellet was washed 
with 200 µl of 70% ethanol and centrifuged for 1 minute. The pellet was vacuum dried 
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PLASMIDS AND PHAGE 
Relevant Characteristics"' 
TFD+, Hgr 
Apr r<mr; delivery plasmid for 
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Bluescript cloning vector, Apf 
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Large scale plasmid isolation ~as by a 10-plate alkaline-SDS procedure. Each 
plate containing a lawn of bacteria was scraped into 5 ml of PBS. The cell mixture 
from 10 plates was separated into 4 Oak Ridge centrifuge tubes and centrifuged at 
5,000 x g, 10 minutes, 4°C. The cell pellet was then suspended in 5 ml of a solution 
containing 2 M glucose, 0.5 M EDTA, 1 M Tris Cl (pH 8.0), and 0.2% lysozyme. The 
sample was incubated for 10 minutes at room temperature. The mixture was 
denatured by adding 10 ml of alkaline-SDS (0.2N NaOH and 1 % w/v SDS), mixed 
and incubated on ice for 20 minutes. To neutralize the mixture, 7.5 ml of 5 M 
potassium acetate (pH 4.8) was added and the mixture was incubated on ice for 10 
minutes. The mixture was centrifuged at 11,000 x g for 30 minutes at 4°C. The 
supernatant was transferred to a clean tube and plasmid DNA was precipitated 
overnight on ice by adding 0.313 volumes of 42% polyethylene glycol, 5 grams 
polyethylene glycol per 8 ml of water. Plasmid DNA was pelleted by centrifuging at 
12,000 rpm, 10 minutes, 4°C. The DNA pellet was resuspended in TE (0.5 mM Tris·Cl 
pH 8.0 and 0.1 mM EDTA) and incubated on ice for 1 hour. The polyethylene glycol 
was removed by centrifuging at 11,000 x g, 10 minutes, 4 ° C. The supernatant, 
containing plasmid DNA, was layered onto a cesium-chloride-ethidium bromide 
gradient and centrifuged at 425,000 g for 4 hours at 20°C in a table-top ultracentrifuge 
(Optima TL, Beckman). Supercoiled plasmid DNA was extracted. The ethidium 
bromide was extracted with water saturated butanol. The DNA was ethanol 
precipitated with 100% ethanol and precipitated overnight at-20°C, and pelleted by 
centrifuging at 12,000 rpm, 15 minutes, 4°C. The pellet was washed with 70% ethanol, 
dried, and dissolved in TE buffer. 
Ligations 
A ligation reaction was set up in a buffer containing 30 mM Tris·HO (pH 7.8), 10 
mM MgCl2, 10 mM DDT, and 1 mM ATP. In each reaction approximately 100 ng of 
the vector, 25 ng of insert, and 1 Weiss unit of T4 DNA ligase were used. Cohesive 
end ligations were performed at 15°C for overnight. 
23 
Construction of Clones 
These clones were used for mini-Mu transposon mutagenesis. The EcoRI-B, Figure 
2, fragment of pJP4 was cloned into pBluescript II KS (pBS). The pBS vector and p}P4 
were digested to completion with EcoRI and mixed in a ligation reaction. Ligation 
reactions were set up as previously described. The ligation mixture was transformed 
into CaCl2 competent DH5a E. coli cells. Transformation was performed by the heat 
shock method. The transformed cells were transferred to Luria Broth medium (LB, 10 
grams Tryptone, 5 grams Yeast Extract, 10 ml NaCl, 10 grams agar for plates, pH 7.5 
per 500 ml water) for 1 hour at 37°C. They were then plated on LB plates containing 
ampicillin (50 µg/ml), IPTG (0.5 mM), and X-Gal (40 µg/ml) to select and screen for 
transformants. White recombinant colonies were picked and checked for the presence 
of insert DNA in vector plasmid by alkaline mini-lysis method of Birnboim-Doly (68). 
When the appropriate clone was obtained, a further subclone of the EcoRI-B 
fragment was created. The pBS EcoRI-B clone was digested completely with EcoRI. 
The digested DNA samples were electrophoresed on a 1.0% low melting agarose gel 
(SeaPlaque, FMC). The DNA was visualized under UV light after ethidium bromide 
staining. The appropriate band was cut out of the gel and the DNA electroeluted out 
of the agarose. The DNA was precipitated with ethanol and resuspended in TE 
buffer. This fragment was completely digested with HindIII and Dral. The pBS vector 
was completely digested with Hindlll and Smal. A ligation reaction was incubated as 
described previously. The ligation mixture was transformed and clones selected as 
previously described. 
The insertion point of the mini-TnS transposon and pJP4 was cloned into the pBS 
plasmid. These clones were then used in DNA sequencing. The p}P4 mini-TnS mutant 
and pBS plasmids were digested with BamHI. A ligation reaction was incubated as 
described previously. The ligation reaction was transformed by the heat shock 
treatment into DH5a. The mixture was plated on LB kanamycin (50 µg/ml) and 
ampicillin (100 µg/ml). The plates were incubated at 37°C. Kanamycin and ampicillin 
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resistant clones were analyzed for insertions by alkaline mini-lysis procedures. 
Plasmid DNA from appropriate clones was then isolated by the 10 plate lysis 
procedure and purified on a CsO gradient. 
Transformation Procedures 
Transformation by the calcium chloride procedure described in Maniatis (68) was 
utilized to transform plasmid DNA into E. coli. A single colony of E. coli was 
inoculated into 5 ml of LB medium, and grown at 37°C overnight with shaking. Four 
m1s of this culture were transferred to 400 ml of fresh LB medium and grown at 37°C 
with shaking. When the culture reached an OD590 of 0.4, it was dispensed into 50 ml 
prechilled Oak Ridge centrifuged tubes and left on ice for 10 minutes. It was 
centrifuged for 5 minutes at 4000g at 4°C to pellet the cells. The cell pellet was 
suspended in half volume ice-cold, sterile CaCl2 solution (50 mM CaCl2 and 10 mM 
Tris•HCl, pH 8.0). The cell suspension was placed in an ice bath for 15 minutes. The 
cells were.centrifuged at 4000 g for 5 minutes at 4°C. The pellet was resuspended in 
1/15 volume CaCl2 solution containing 10% glycerol. 200 µ1 aliquots of competent 
cells were dispensed into prechilled, sterile tubes and stored at -70°C until needed. 
When transformation was performed, the cells were thawed and placed on ice. 40 ng 
of DNA dissolved in 50 µl of TE was mixed with the cell suspension and incubated on 
ice for 30 minutes. The mixture was heat shocked in a water bath heated to 42°C, for 
2 minutes. 1.0 ml of SOC (0.5% Yeast Extract, 2.0% Tryptone, 10.0 mM NaO, 2.5 mM 
KCl, 10.0 mM MgCl2, 10.0 mM MgS04, 20.0 mM Glucose) was added to each sample 
and incubated at 37°C for 1 hour. The mixture was plated on selective media and 
incubated overnight to allow for growth. 
Cells that were used in transformation using the electroporation technique were 
prepared as follows. A 5 ml culture was inoculated with the appropriate cells and 
incubated overnight. This culture was then used to inoculate 500 ml of appropriate 
media. The culture was allowed to grow to an OD60o of 0.5 to 1.0. The cells were 
dispensed into prechilled centrifuge bottles and chilled on ice for 10 minutes. The cells 
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were centrifuged at 4000 g for 5 minutes at 4°C. The pellet was resuspended in equal 
volume of ice-cold, sterile water and centrifuged at 4000 g for 5 minutes at 4°C. The 
pellet was resuspended in half volume of ice-cold, sterile water and centrifuged at 
4000 g for 5 minutes at 4°C. The half volume wash and centrifuge steps were 
repeated. The pellet was resuspended in 0.02 volumes ice-cold, sterile water and 
centrifuged at 4000 g for 5 minutes at 4°C. The final pellet was resuspended in 0.002 
volumes of 10% glycerol and water. The cells were dispensed into prechilled micro-
centrifuge tubes in a volume of 80 µ1 and stored at -70°C. 
When the electroporation was perfomed all the materials were kept on ice. The 
cells were thawed and placed on ice. DNA was added in a volume of 4 µl. The 
mixture was chilled and added to an electroporation cuvette that was on ice for 5 
minutes. The following conditions were used to electroporate cells in a BTX Electro 
Cell Manipulator 600: charging voltage 2.45 kV, resistance R5 (129 ohm), field 
strength 12.25 kV I cm, pulse length 5 to 6 msec. Following electroporation, 1 ml of 
SOC was added and the mixture incubated at 30°C for 1 hour. The cells were plated 
on selective media and incubated overnight. 
Electroelution Techniques 
Following electrophoresis on an agarose gel, the gel was visualized on a UV light 
source. Appropriate DNA bands were cut out of the agarose gel and placed into a 
dialysis membrane (Spectrapor membrane tubing, m.w. cutoff: 12,000 to 14,000). A 
minimal amount of TE was added to cover the gel. The membrane was placed in an 
IBI electrophoresis chamber. The membrane was covered with O.Sx Tris-borate 
electroporesis buffer (concentrated stock Sx per liter: 54 grams Tris base, 27.5 grams 
boric add, 20 ml 0.5 M EDTA pH 8.0). The DNA was electrophoresed at 100 volts 
until the DNA had moved out of the gel. This was tested by examining the presence of 
DNA in the agarose gel on a UV lamp. Once the DNA had moved out of the gel, the 
electrodes on the electrophoresis chamber were reversed and run for 2 minutes at 100 
volts. The buffer was removed from the dialysis membrane and the DNA precipitated 
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by adding 1 /10 volume of 7.5 M ammonium acetate and 2X volume of 100% ethanol 
The DNA was incubated on ice for 10 minutes. The mixture was spun in a Beckman 
· Microcentrifuge at full speed for 5 minutes. The pellet was washed with 70% ethanol 
and vacuum dried for 5 minutes. The final pellet was resuspended in TE. 
Transposon Mutagenesis 
Several methods were chosen to produce lac fusions in the plasmid pJP4. In order 
to produce lac fusions within the structural genes of the TFD pathway, transposon 
mutagenesis using a Tn3 transposon, developed by Stachel et aL (101), mini-Tn5, 
developed by de Lorenzo et al. (29), and a mini-Mu phage system, developed by 
Castilho et al. (15) were utilized. The mutagenesis was attempted in pJP4 plasmid as 
well as a subcloned portion of pJP4. Tn3 and mini-Tn5 transposons were utilized to 
produce gene fusions directly in pJP4, and mini-Mu was used to produce fusions in 
cloned segments of pJP4. Marker exchange experiments were used to replace wild type 
regions with the mutated mini-Mu regions. 
Tn3 Transposon Mutagenesis 
Transpositions into target DNA sequences were selected by the transconjugant 
procedure of Heffron et aL (48). The plasmid pJP4 was conjugated into strain HB101 
pHoHol, pSSHe from AEK101 pJP4 by the method previously described (48). The 
pJP4 plasmid became the target sequence. HB101 pHoHol pSShe pJP4 isolates were 
selected for growth on BHI with mercury (100 µg/ml), ampicillin (100 µg/ml), and 
chloramphenicol (100 µg/ml). The HB101 pHoHolpSShe pJP4 strain was mated with 
SF800. HB101 pHoHol pSShe pJP4 was grown overnight in 5 ml BHI with mercury 
(100 µg/ml), ampicillin (100 µg/ml), and chloramphenicol (100 µg/ml). SF800 was 
grown in 5 ml of LB nalidixic acid (60 µg/ml). Both cultures were incubated shaking, 
overnight, at 37°C. The cultures were mixed in a 1:1 ratio and spotted on LB plates. 
The plates were incubated at 37°C for 6 to 8 hours. The plates were then scraped with 
1 ml of PBS, the mixture pelleted, resuspended in 100 µl PBS and plated on BHI 
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mercury (100 µg/ml), ampicillin (100 µg/ml), and nalidixic acid (60 µg/ml). The 
plates were incubated overnight at 37°C. 
Tn5 Transposon Mutagenesis 
In a typical mating experiment, the donor strain E. coli S17-1 carrying the plasmid 
pUT mini-Tn5 lacZ1 was grown overnight shaking at 37°C in 5 ml of LB medium 
containing 100 µg/ml ampicillin and 50 µg/ml kanamydn. AEK101 containing pJP4 
was grown overnight shaking at 30°C in 5 ml of TNA medium. After overnight growth 
the cultures were mixed and centrifuged at 1,500 g for 10 minutes in a Sorvall 
centrifuge. The pellet was resuspended in 0.05 ml of PBS. The suspension was 
dropped on a TNA plate. The plate was incubated at 30°C for 6 to 8 hours. After 
incubation, the cells were scraped off the plates into 1 ml of PBS. 0.1 ml of the cell 
resuspension was plated on BHI (18.5 grams brain heart infusion, 10 grams agar for 
plates per 500 ml water) containing 150 µg/ml rifampicin, 100 µg/ml mercury, and 50 
µg/ml kanamydn. The plates were incubated at 300c overnight. 
Mini-Mu Transposon Mutagenesis 
The pBS tfdDEF subclone of pJP4 was transformed into POII1734 by the heat 
shock method. Movement of the phage was then induced by temperature induction. A 
5 ml culture was inoculted and incubated overnight at 30°C. A fresh culture was 
inoculated at a ratio of 50:1 and incubated for 2 hol.ll's at 30°C. The culture was then 
transferred to 42°C and incubated for 25 minutes. The culture was incubated at 37°C 
until lysis. Lysis was presumed to have occurred after 50 minutes if a clearing of the 
culture was not observed. Following lysis, chloroform was added to a concentration of 
1 % and the mixture was incubated at room temperature for 5 minutes. Cell debris and 
chloroform were pelleted by centrifuging at 5,000 g for 5 minutes, 4°C. The super-
natant was removed and used immediately or stored at 4°C. After induction of the 
phage, infection of M8820 cells was performed. M8820 was grown to early log phase. 
The M8820 culture and phage lysate were mixed in a ratio of 2:1 and incubated at 
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22°C for 30 minutes. Following incubation, 1 ml of SOC was added and cultures 
· incubated at 30°C for 1 hour. The cell-phage mixture was then spread onto LB plates 
ampicillin (100 µg/ml), kanamycin (100 µg/ml), and streptomycin (100 µg/ml). The 
isolated colonies were then examined for the presence of the polll 734 phage in the 
plasmid. This was done by isolating the plasmid using the Birnboim-Doly alkaline-
SDS method (11) and restriction enzyme analysis. The restriction enzymes used were 
Kpnl and Spel. 
Marker Exchange Experiments 
The pBS tfdDEF fusion plasmids were used in the marker exchange experiments. 
A variety of procedures were attempted to produce recombinational events. The first 
procedure utilized circular plasmid DNA. The pBS tfdDEF mini-Mu insertions were 
electroporated into AEK101 pJP4 as previously described. The transformants were 
plated on BHI mercury (100 µg/ml) plates and incubated overnight at 30°C. The lawn 
of bacteria that grew was scraped off these plates, serial diluted, and plated on BHI 
mercury (100 µg/ml) and kanamycin (50 µg/ml). Following the growth of trans-
formants on mercury and kanamycin, isolates were picked and tested for the ability to 
grow on carbenicillin (50 µg/ml). The antibiotic resistance marker on pBS is ampicillin. 
Carbenicilin is substituted for ampicillin when Alcaligenes strains are used to test for 
growth on the antibiotic. Alcaligenes is naturally resistant to ampicillin. Growth 
studies were used to determine if a single or double crossover event occurred. 
Linear transformation experiments were then attempted. The pBS tfdDEF fusion 
plasmids were digested with the restriction enzyme Seal. This linear plasmid was then 
transformed into E. coli. strains JC7623 pJP4 and DPB271 pJP4 and AEK101 pJP4 by 
electroporation. In addition to these procedures, the fusion plasmids were digested 
completely with Apal and Spel. The restriction digests were separated on an agarose 
gel and the band containing the cloned portion of the pathway and mini-Mu trans-
poson were cut out of the gel and the DNA isolated by electroelution. This linear 
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portion of DNA was then transformed into JC7623 pJP4 and DPB271 pJP4 by 
electroporation. 
Following electroporation the cells were plated on BHI containing mercury and 
incubated overnight at 30°C. The lawn of bacteria was then scraped off with PBS and 
the cells plated on BHI containing mercury (100 µg/ml) and kanamycin (50 µg/ml). 
The isolates that were produced by transformation with linear DNA using Seal were 
then tested for the ability to grow on carbenicillin (50 µg/ml). 
Analysis of Transposon Mutants 
Following the production of transposon mutants, a scheme was designed to 
determine if the proper transpositional event had occurred. Once it was determined 
that a transposition event of interest had occurred, the expression of the lac fusion 
genes under inducing and noninducing conditions was determined. 
Analysis of Tn5 Transposon Mutants 
Growth on TFD as a Carbon Source. Following the conjugation of E.coli 517-1 
carrying the plasmid pUT mini-Tn5 lacZ1 with AEK101 pJP4 the rifampicin resistant, 
mercury resistant, kanamycin resistant transconjugants were tested for the ability to 
grow on TFD as a sole carbon source. Single colonies were picked from the BHI 
rifampicin (150 µg/ml), mercury (100 µg/ml), and kanamycin (50 µg/ml) plates. The 
colonies were replica-plated onto BHI plates containing 150 µg/ml rifampicin, 100 
µg/ml mercury, and 50 µg/ml kanamycin plates and mineral medium plates (MMO; 40 
ml solution A, 1 M Na2 HP04, 1 M KH2P04; 20 ml solution B, 10.0 g nitriloacetate, 
14.45 g Mg•S04 •7H20, 3.34 g CalC}i•2H20, 9.25 mg CNH4)6 M07()24•4H20, 0.1 g 
FeS04•7H20, 50 ml metal "44" per 1000 ml; metal 44, 0.25 g EDTA, 0.5 g FeS04 
•7H20, 0.154 g MnS04•H20, 0.039 g CuS04•SH20, 0.025 g CO (N03)i•6H20, 0.11 
Mg 2n504•7H20, 0.18 mg Na2 B407•0H20 per 100 ml; 10 ml solution C, 10% (Nfi4)i 
504) plates containing 0.3% case amino acids (CAA), 0.05% TFD. The replica pattern 
consisted of 128 colonies picked onto a plate. Two of the colonies were AEK101 pJP4 
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and two were AEK101. These were used as positive and negative controls. The plates 
were incubated at 30°C overnight. After growth on the MMO 0.3% CAA, 0.05% TFD 
plates the colonies were replica plated to MMO 0.05% TFD plates. These plates were 
incubated overnight at 30°C. 
The colonies that were unable to grow on MMO 0.05% TFD plates were then 
tested for the ability to grow on TFD as a sole carbon source in liquid cultures. 5 ml of 
MMO 0.3% CAA, 0.05% TFD liquid cultures in 16 mm test tubes were inoculated with 
cultures that were unable to grow on MMO 0.05% TFD plates. The test tubes were 
incubated, shaking on a test tube rack at 30°C overnight. After overnight incubation 
the cultures were tested for the presence of TFD. One ml of the culture was analyzed 
using a Shimadzu UV160U UV-Visible recording spectrophotometer. A scanning 
photometric analysis was performed at 240 nm to 320 nm. This range of wavelengths 
will produce a peak that has a maximum absorbance at 277 nm when TFD is present. 
AEK101 and AEK101 pJP4 were grown under the same conditions and used as 
negative and positive controls. 
Conjugation of Kanamycin Resistance. Once it was determined that mini-Tn5 
transposon isolates were not able to utilize TFD as a sole carbon source, the ability to 
transfer kanamycin resistance through conjugation was studied. This will demonstrate 
the presence of mini-Tn5 on the plasmid. AEK101 pJP4 Tn5 transconjugants were 
grown overnight in a 16 mm test tube containing 5 ml of BHI mercury (100 µg/ml), 
kanamycin (50 µg/ml) broth overnight, shaking in a test tube rack at 30°C. PP0300 
was grown in a 16 mm test tube containing 5 ml of TNB (2.5 grams Tryptone, 1.25 
grams Yeast Extract, 0.5 grams Dextrose, 2.5 grams NaCl, 2.0 grams KN03 per 500 
ml) containing nalidixic acid (60 mg/ml) overnight, shaking, in a test tube rack, at 
30°C. After overnight growth the cultures were mixed and centrifuged in 15 ml 
Beckmann glass centrifuge tubes, 5,000 rpm, 5 minutes, room temperature. The pellet 
was resuspended in 0.05 ml of PBS and spotted onto TNA plates. The plates were 
incubated for 6 to 8 hours at 30°C. Following this incubation the cells were scraped off 
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the TNA plates using 1 ml of PBS. This mixture was plated onto BHI plates 
containing 60 µg/ml nalidixic acid, 100 µg/ml mercury, and 50 µg/ml kanamycin. The 
plates were incubated overnight at 30°C. The isolates were then replica plated to BHI 
60 µg/ml nalidixic acid, 100 µg/ml mercury, and 50 µg/ml kanamycin plates. Growth 
on these plates revealed that kanamycin resistance was conjugated from AEKl 01 to 
PP0300. 
Assay of 6-Galactosidase Activity. Following the analysis by growth on TFD as a 
carbon source and transfer of kanamycin resistance by conjugation, expression levels 
of 13-galactosidase were determined. Expression studies were performed under 
inducing and noninducing conditions using AEKlOl pJP4 mini-Tn5 isolates. Inducing 
conditions contained TFD in the media and noninducing conditions contained no TFD. 
The assays were performed as described by Miller (72). Cultures of 5 ml MMO 
0.3% CAA and 5 ml MMO 0.3% CAA, 0.05% TFD in 16 mm test tubes were 
inoculated and grown overnight shaking at 30°C. The overnight cultures were 
subcultured into fresh media of the same type. Four drops of the overnight culture 
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were added to 5 ml of fresh media. The cultures were incubated at 30°C shaking until 
the cultures reached an 0D600 of 0.28-0.70. The cultures were cooled to prevent 
further growth by immersing in an ice bucket containing a mixture of ice and water. 
After 20 minutes the cultures were assayed and the bacterial density measured. 
The cell density was recorded by measuring the absorbance at 600 nm. One ml of 
the culture was withdrawn for the measurment. Aliquots of the cultures were added 
to the assay medium, Z buffer (0.06 M Na2HP04·7H20, 0.04 M NaH2P04·H20, 0.01 
M KCl, 0.001 M MgS04·7H20, 0.05 M 13-mercaptoethanol, pH 7.0). 0.2 ml of the 
culture was added to 0.8 ml of Z buffer. Two drops of chloroform and 1 drop of 0.1 % 
SDS solution was added to each ml of assay mix. The mixtures were vortexed for 10 
seconds. This process disrupts the cell membrane, allowing small molecules, such as 
ONPG, to diffuse into the cell. The tubes were placed in a water bath at 28°C for 5 
minutes. The reaction is started by adding 0.2 ml of ONPG (4 mg/ml in Z buffer) to 
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each tube and shaking for a few seconds. The time of the reaction was recorded. The 
reaction is stopped by adding 0.5 ml of a 1 M Na2C03 solution after sufficient yellow 
color has developed. AEK101 and AEK101 p}P4 were inoculated as negative controls. 
The optical· density was recorded at both 420 nm and 550 nm for each sample. 
The reading at 420 nm is a combination of o-nitrophenol and light scattering by cell 
debris. The reading at 550 nm represents light scattering. The following formula is 
then utilized: 
Units = 1000 X OD 420 -1. 75 x OD550 
tx vxOD60o 
OD420 and OD550 are read from the reaction mixture; 
OD600 reflects the cell density just before assay; 
t = time of the reaction in minutes; and 
v = volume of culture used in assay, in ml. 
The units are proportional to the increase in o-nitrophenol per minute per bacterium. 
Sequencing. Once it was established that an isolate was able to transfer kana-
mycin resistance and the ~-galactosidase expression level was determined, the site of 
insertion was determined. The isolation of plasmid was performed as described by 
large-scale lysis in the DNA manipulation section. The insertion point of the mini-Tn5 
transposon was cloned into pBS. These isolates were then sequenced. 
The clones were sequenced at the Sarkeys Biochemistry Core Facility. Sequence 
data were produced by an Applied Biosystems automated sequencer. The sequence 
data were aligned using MacV ector 4.1 program. 
Analysis of Tn3 Transposon Mutants 
SF800 p}P4::Tn3 transconjugants were mated with AEK101. SF800 pJP4 Tn3 
transconjugants were grown in 5 ml of BHI mercury (100 µg/ml), ampicillin (100 
µg/ml), and nalidixic acid (60 µg/ml). AEK101 was grown in 5 ml of TNA. The 
cultures were incubated, shaking, overnight at 37°C and 30°C, respectively. After 
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overnight growth, the cultures were mixed and spotted as described before. After 
scraping, the mixture was plated onto BHI mercury (100 µg/ml), ampicillin (100 
µg/ml), and rifampicin (100 µg/ml) plates. The plates were incubated at 30°C 
overnight. 
The AEK101 pJP4::Tn3 transconjugants were then tested for the ability to grow on 
TFD as a sole carbon source. The procedure was the same as described for mini-Tn5 
insertions. 
Analysis of Mini-Mu Transpositional Events 
The kanamycin resistant mini-Mu transconjugants were tested for the ability to 
grow on TFD as a sole carbon source. This was done as previously described. 
Following the growth tests Southern blotting and hybridizations were performed to 
identify mini-Mu marker exchange events. 
Southern Blotting: and Hybridization 
Ag-arose Gel Electrophoresis. Agarose gel electrophoresis was performed as 
described by Maniatis (68). BamHI restriction digests of the plasmids were separated 
on a 1.0% agarose gel. The agarose gel was prepared and electrophoresed in 0.Sx Tris-
borate electroporesis buffer (concentrated stock 5x per liter: 54 grams Tris base, 27.5 
grams boric acid, 20 ml 0.5 M EDTA pH 8.0). 
Gel Pretreatment and Transfer to Nylon Membrane. Following electrophoresis, the 
DNA on the gel was depurinated by soaking the gel in 0.25 M HCl twice for 15 
minutes each. The DNA was denatured by soaking the gel two times for 15 minutes in 
a solution of 0.5 M NaOH and 1.5 M NaCL Soaking the gel twice for 15 minutes each 
time in 0.5 M Tris and 1.5 M NaCl (pH 7.0) resulted in neutralization. The DNA was 
transferred to a Nylon membrane (Zeta probe GT, BioRad) with vacuum blotter 
(Milliblot-V, Millipore) using 10x SSC transfer solution (1.5 M NaCl and 0.15 M 
sodium citrate). 
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Hybridization. Following transfer, the membrane was rinsed in 2x SSC and air 
dried. The membrane was then dried in a vacuum-oven at 80°C for 30 minutes. 
Prehybribization was started by sealing the membrane in a heat sealable bag containing 
0.25 M Na2HP04 (pH 7.2) and 7% w /v SDS hybridization solution and incubating 
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the bag at 65 C for 2 to 4 hours. The hybridization solution was replaced with fresh 
solution. The probe was heat denatured by incubating in boiling water for 5 minutes. 
Heat denatured DNA probe was added to the solution and the bag resealed. 
Hybridization was conducted by incubating the bag at 65°C for 16 hours with 
agitation. The membrane was removed from the bag and washed twice for 30 minutes 
in 20 mM Na2HP04 (pH 7.2) and 5% w/v SDS solution at 65°C. Two more washes 
for 45 minutes in 20 mM Na2HP04 (pH 7.2) and 1 % SDS solution at 65°C were 
performed next. The wet membrane was exposed to X-ray film. The film was 
processed according to the manufacturer's instructions. 
Preparation of DNA Probe. The DNA probe used in Southern hybridization 
consisted of the 1.5 kb BglIT-BamHI fragment of the mini-Mu phage. This fragment 
consisted of the kanamycin resistant gene in the mini-Mu phage. The band was 
isolated by digesting poll1734 plasmid DNA, containing the mini-Mu phage, with BglIT 
and BamHI restriction enzymes. The DNA was separated on an agarose gel and the 
appropriate band was cut out of the agarose gel and isolated by electroelution. The 
DNA was labeled by nick translation. 
Nick Translation. Nick translation was performed by a Promega nick translation 
kit. Reactions contained 1 µg of probe DNA, 10 µl of nucleotide mix (5 µMeach of 
cold dCTP, dGTP, dTTP), 5 µl of nick translation buffer (50 mM Tris-HCl, pH 7.2 and 
10 mM MgS04), 7 µl of [a-32p] dATP (400 Ci/mM at 10 mCi/ml), 5 µl of enzyme 
mix (DNA polymerase I at 1 U/µl and DNase I at 0.2 ng/µ1) and sterile water for a 
final volume of 50 µI. The reaction mixture was incubated at 15°C for 1 hour. The 
reaction was stopped by adding 5 µl of 0.2 M EDTA (pH 8.0). Unincorporated label 
was removed by selectively precipitating the DNA with ammonium acetate and 
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ethanol. The ethanol was pelleted after a 70% ethanol wash and dissolved in TE (10 




Tn3 Transposon Mutagenesis 
Isolation and Characterization of Tn3 Induced Mutants 
A system developed by Stachel et al (101) was used that enables the transfer of a 
modified Tn3 transposon. The modified Tn3 transposon contains the lacZYA genes. 
The transposon can be used in the generation of both transcriptional and translational 
lac fusions with plasmid DNA sequences and these fusions are stable. 
The target plasmid, pJP4, was transformed into the transposon donor strain, 
HB101 pHoHol, pSShe. The resulting strain contained pJP4 and allows for the trans-
position of Tn3 out of the pHoHol plasmid and into pJP4. This strain was mated with 
SFSOO. Conjugation of the HB101 strain with SFSOO allows the pHoHol and pSShe to 
be moved into environments in which they are unable to replicate. Replication of 
pHoHol and pSShe is dependent on DNA polymerase I, the polA gene product. SFSOO 
is a polA mutant and will not support the replication of these plasmids. The Tn3 is 
maintained if it transposes into the pJP4 plasmid that is able to replicate in SFSOO. The 
Tn3 transposon is not able to further transpose because the transposase on pSShe is not 
replicated in this environment. 
Following the successful conjugation of pJP4 into HB101 pHoHol, pSShe the 
conjugation with SFSOO was performed. The result of this conjugation was the transfer 
of pJP4, containing the Tn3-lac transposon, into SFSOO. The resulting isolates were 
mercury, ampicillin, and nalidixic acid resistant. The pJP4::Tn3 plasmids were able to 
be successfully conjugated to SFSOO. Isolates that were produced showed mercury, 
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ampicillin, and nalidixic acid resistance. This showed that the Tn3 transposon was 
able to be transposed into pJP4. 
The next step was to determine if any insertions occurred in genes of the TFD 
pathway. E. coli is unable to metabolize TFD as a sole carbon source. Since growth on 
TFD was the easiest initial screen, these plasmids were conjugated to a strain that is 
able to metabolize TFD. AEK101 was used in conjugation studies to test for metab-
olism of TFD as a sole carbon source. 
The SFSOO pJP4::Tn3 isolates were conjugated to AEK101 as a mixed culture of 
isolates. Selection of transconjugants occurred on rifampicin (150 µg/ml), mercury 
(100 µg/ml), and carbenicillin (50 µg/ml). The result of this selection was trans-
conjugants of AEKlOl that contain pJP4 with the Tn3 transposon inserted. Individual 
isolates were then tested for the ability to grow on TFD as a sole carbon source. The 
replica plating technique on MMO 0.3% CAA 0.05% TFD and MMO 0.05% TFD plates 
was performed as described previously. 
Approximately 5,000 individual isolates were picked and replica-plated. Of these 
isolates, none lacked the ability to grow on TFD as a sole carbon source. 
Mini-Mu Phage Mutagenesis 
Cloning of pTP4 
The EcoRI-B fragment of pJP4 was succesfully cloned into pBS. The EcoRI-B 
fragment of pJP4 contains the tfdB and tfdCDEF operons. From this clone, a Hindlll-
Srnal clone was produced in pBS. This clone contains contains the 300 base pairs of the 
3' end of the tfdD gene sequence and the complete nucleotide sequence of the tfdE and 
tfdF gene sequences. 
Induction of Mini-Mu 
The pBS tfdDEF clone was transformed into POII1734 by the heat shock method. 
This strain was used for the production of mini-Mu lac fusions and contains a 
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temperature- sensitive transposase gene in the Mu phage present in the chromosome. 
The temperature-sensitive phage supplies transposition and replicative functions of 
Mu in trans. The mini-Mu prophage replicates and transposes hundreds of times in 
each cell and occasionally inserts into the pBS tfdDEF plasmid by a cointegrate 
transposition event (15). Mu DNA sequences are then packaged into Mu phage heads 
from the Mu left end to include 38 kb of DNA (14). If packaging starts from a mini-Mu 
sequence on the left side of a mini-Mu plasmid cointegrate stucture and if the size of 
the mini-Mu plus the size of pBS tfdDEF is less than 38 kb, then duplicated copies of 
mini-Mu sequences will be packaged. Multiple copies of the plasmid could also be 
packaged. Upon infection of a new cell with a particle containing multimeric plasmid, 
homologous recombination can occur between the duplicated plasmids to form a 
plasmid without an insertion. Insertions of mini-Mu into multimer forms of a plasmid 
are unstable since recombination can occur between duplicated plasmid sequences 
with the loss of insertion. 
Analysis of Mini-Mu Insertions 
Once the phage induction experiments were performed, isolates were examined 
for appropriate mini-Mu lac fusions. The cloned fragment in pBS tfdDEF contains an 
internal Kpnl restriction site 800 bp from the Hindill site used in cloning. Thirty base 
pairs from the Hindll site in the multiple cloning site is another Kpnl site. At the other 
end of the clone, in the multiple cloning site of pBS, an Spel restriction site is present. 
These two restriction sites were not found to occur elsewhere in the plasmid and were 
used in the analysis of clones. 
Digestion of pBS tfdDEF with Kpnl and Spel produced three fragments. The pBS 
vector produced a fragment of approximately 2.8 Kb. The insert of the clone produced 
two fragments. One of the fragments was approximately 1.5 kb and contains the 
complete tfdF nucleotide sequence and approximately 200 base pairs of the 3' end of 
tfdB next to tfdF in the operon. The remaining fragment was approximately 800 base 
pairs in length. The smallest fragment contained the remaining portion of tfdB, 
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approximately 520 base pairs, and the portion of tfdD that was cloned. Utilizing these 
restriction sites, it was possible to determine if the insertion had occurred in the pBS 
vector or in genes of interest. In addition to determining insertions in the vector, the 
general location of the insert within the tfdDEF region was also determined. 
Initial analysis of 50 mini-Mu fusion isolates showed that 49 of these possible 
fusion mutants did not contain an insertion. This showed that the majority of 
transpositional events that occurred resulted in multimeric forms of mini-Mu phage 
and pBS tfdDEF plasmids. The majority of multimers that were formed undergo a 
homologous recombinational event. The result was that the mini-Mu phage recom-
bines out and the resulting plasmid was the pBS tfdDEF plasmid. 
In order to prevent this recombinational event from being the major type of 
plasmids isolated, an additional plasmid isolation and transformation step was 
performed. Following the heat induction and transduction into M8820 a large scale 
plasmid prep was performed. The resulting plasmid prep contained a mixed 
population of pBS tfdDEF. Some of these contained mini-Mu phage in a variety of 
positions and a large portion contained no phage. The plasmids that contain no mini-
Mu phage were then separated from the mixture. This was performed by transforming 
the plasmid mixture into M8820 by the heat schock method. By selecting for 
kanamycin, the plasmids that contained no mini-Mu phage were unable to grow on LB 
kanamycin (50 µg/ml) plates. Only those plasmids that contained a phage were able 
to replicate and produce a colony. 
The isolates that were produced by this procedure were then analyzed. The 
plasmids were isolated by mini-lysis procedure and examined by restrictional enzyme 
analysis and agarose gel electrophoresis. Of the 100 isolates analyzed, 46 contained an 
insertion in the cloned region containing the tfdDEF genes. The remaining 54 were in 
the pBS plasmid. Of the 46 plasmids containing insertions in the tfdDEF genes, 44 of 
the insertions were in the 888 bp fragment. The remaining 2 isolates were in the 1.5 kb 
fragment. This appears to be an unusually large number of insertions in the smaller 
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888 bp region. Random insertion of mini-Mu should result in a larger number of 
insertions in the 1.5 kb region. 
Homologous Recombination Experiments 
Following the insertion of mini-Mu phage into the tfdDEF gene region in the pBS 
clone, the insertion mutant had to be inserted into pJP4. This was attempted by a 
homologous recombination event. Significant amounts of homologous DNA should 
exist on both sides of the mini-Mu point of insertion to allow for a recombination 
event. A double crossover event would result in the replacement of wild-type 
segments of pJP4 with the mutated fragment. 
The first attempt to produce homologous recombinational events involved 
electroporating circular mini-Mu fusion plasmids into AEK101 pJP4. The pBS plasmid 
contains a ColEl origin of replication and is unable to replicate in AEK101. A 
recombination event would result in incorporation of the kanamycin resistant gene of 
mini-Mu. A possible recombination event could then be selected for by growth on 
kanamycin. Growth on carbenicillin could then be analyzed to distinguish between 
single and double crossover events. A double-crossover event would result in 
incorporation of kanamycin resistance in p JP4. A single-crossover event would 
produce a colony that is kanamycin and carbenicillin resistant. Carbenicillin is the 
antibiotic resistance marker on pBS. Approximately 100 isolates were picked and 
found to be kanamycin and mercury resistant. The isolates were· then tested for the 
ability to grow on carbenicillin. All of the isolates showed the ability to grow on 
carbenicillin. This showed that all the recombinational events were the result of 
single-crossover events. 
Since this homologous recombination event did not produce a double-crossover 
event, a new approach was tried. This procedure depended. on homologous recombin-
ation using linear DNA. Two E. coli strains have been developed for use in linear 
transformation: JC7623 and DPB271 (55, 113). 
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In addition to using these E.coli strains, the transformation of linear DNA was 
performed with AEKlOl. The circular plasmid DNA was linearized and electro-
porated into AEKlOl pJP4. The mini-Mu containing plasmids were digested with Seal. 
The pBS plasmid contains a single Seal restriction site. The site is present in the 
ampicillin gene of pBS. The linear fragment contained the tfdDEF insert with a mini-
Mu insertion. Depending on where the insertion occurred, homologous flanking DNA 
should occur on each side of the insertion. The regions are homologous to regions on 
pJP4. If a recombination event occurred, the mini-Mu insertion would recombine into 
pJP4. The wild-type segment would recombine out and the pBS DNA segments would 
also be lost following the recombination. 
No kanamycin resistant AEKlOl pJP4 transformants were produced using linear 
DNA. Following the growth on BHI mercury (100 µg/ml), the lawn of bacteria was 
plated on BHI mercury (100 µg/ml) kanamycin (50 µg/ml) plates. No isolates were 
produced that had the ability to grow on kanamycin. This suggested that AEK101 was 
unable to take up linear DNA. 
Since the use of AEK101 did not result in the appropriate recombination event, the 
E. coli strains capable of taking up linear DNA were used. Two types of linear 
transformation experiments were performed. One involved digesting the mini-Mu 
fusion plasmid with Seal and transforming the linearized DNA fragment. The second 
was used to increase the chances of producing a recombinational event, the vector 
DNA was separated from the cloned segment of DNA with the mini-Mu DNA fusion. 
The samples were digested with Spel and Apal. The result of this digestion was two 
fragments. One fragment contained the mini-Mu insertion and cloned DNA fragment; 
the other fragment contained the pBS vector. These isolates were separated on an 
agarose gel. The mini-Mu and cloned DNA fragments were isolated from the agarose 
gel by the electroelution process as described in Materials and Methods. This fragment 
was then transformed, followed by selection for a homologous recombination event. 
The lawn of JC7623 pJP4 and DPB271 pJP4 isolates produced after electroporation was 
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plated onto BHI mercury (100 µg/ml) and kanamycin (50 µg/ml) plates. Kanamycin-
resistant isolates were produced on the BHI mercury kanamycin plates. The linear 
transformation using the single digested mini-Mu fusion plasmid with Seal produced a 
small number of kanamycin resistant isolates. The linear transformation procedure 
utilizing two restriction enzymes was much more efficient. About twice as many 
kanamycin mercury kanamycin isolates were produced. Using the two-restriction 
enzyme method, 26 isolates were obtained. 
The next step was to determine if the recombination event occurred in pJP4. The 
plasmids were isolated by 10 plate lysis. The plasmids were digested with BamHI and 
Hindill restriction enzymes and separated on a gel. Two distinct types of plasmids 
were isolated. One appeared to have an identical pattern on the gel as wild-type p}P4. 
Southern hybridizations were then performed to determine if a recombination event 
could have occurred that produced a wild-type pattern of pJP4. A 1.5 kb portion of the 
kanamycin gene was used as the probe. The probe was isolated from the pOII1734 
plasmid by using the restriction enzymes BamHI and Bglll. The Southern hybrid-
ization showed that no recombination event had occurred. The positive control, 
p0II1734 plasmid, produced a band in the audioradiogram at 9.7 kb. No other bands 
showed a hybridization pattern on the audioradiogram. The negative control was 
pJP4. These results showed that no recombination event had occurred in these 
plasmids. 
Another type of plasmid was produced in the homologous recombination events 
performed. When p}P4 was digested with BamHI, six bands were produced: A: 39.4 
kb, B: 14.4 kb, C: 11.9 kb, D: 6.5 kb, E: 3.6kb, and F: 3.3 kb. Several homologous 
recombinants were produced that had an altered pattern from the wild-type p}P4. 
When digested with BamHI, the mutants produced bands at approximately 39.4 kb, 
7.0 kb, 6.0 kb, 2.0 kb, and 1.7 kb. 
The restriction pattern using Hindlll was also determined. When a restriction 
digest of p}P4 was electrophoresed on an agarose gel, the following bands were 
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produced: A: 34.7 kb, B: 22.2 kb, C: 8.0 kb, D: 6;4 kb, E: 4.1 kb, F 2.0 kb, G: 1.6 kb, and 
H: 1.4 kb. When the homologous recombinants were digested using HindIII and 
elecectrophoresed, three bands could be easily identified. The sizes were 34.7 kb, 18.0 
kb and 6.4 kb. Figure 3 is an agarose gel picture of two isolates that are characteristic 
of the deletion observed. The molecular weight standard A digested with Hindm is in 
Lane 1. Two isolates showing a deletion with the production of an 18.0 kb fragment 
are in Lanes 2 and 3. The plasmid pJP4 digested with HindllI is in Lane 4. The 
appropriate band sizes for each fragment are shown on the side of the picture. 
In order to get an idea of the homologous recombination event that occurred, a 
Southern hybridization was performed. The samples were digested with HindID and 
the Southern hybridization was performed as described in Materials and Methods. 
The probe that was used for these hybridization studies was an ApaI-SpeI fragment 
from the pBS tfdDEF clone. The probe contained the 3' portion of tfdD and complete 
sequences of tfdE and tfdF. This probe was used to determine if these gene sequences 
were present in the mutants. 
The positive control used in the Southern was pJP4. The genes of the probe were 
present in the 8.0 kb Hindm C fragment. This 8.0 kb fragment in the control produced 
a signal. The pBS plasmid was used as a negative control and produced no signal. The 
samples that were utilized were those mini-Mu insertions that produced the altered 
pattern compared to pJP4. These were the same isolates that the mini-Mu phage 
were inserted in the 1.5 kb SpeI-KpnI fragment. The 18.0 kb fragment in a Hindill digest 
produced a signal. No other bands produced any signal on the autoradiogram. The 
18.0 kb Hindm fragment that was present in these fusion mutants contained some 
portion of the tfdDEF genes in the TFD pathway. Five isolates were analyzed using the 
tfdDEF cloned segment in pBS. All showed the same pattern on the autoradiogram. 
Figure 4 is the audioradiograph of two of the deletion mutants. The deletion mutants 
were in Lanes 3 and 5. The 18.0 kb fragment produced a signal. The Hindm C frag-
ment of p JP4 produced a signal from pJP4. A negative control, pBS, was also included. 
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Figure 3. Agarose Gel of Deletion Recombinants That Were 
Produced During Homologous Recombination 
Studies. The samples were digested with the 
restriction enzyme Hindill. Numbers represent 
fragment sizes in kilobases; letters represent 
fragment designations of a pJP4 Hindill digest. 
The 18.0 kb band is the band that was created 
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.,_ Deletion fragment 18.0 kb 
.,_pJP4HindllIC 8.0 kb 
Figure 4. Audioradiograph of Deletion Mutants. The probe 
contains tfdDEF genes of pJP4 labeled with a-
32P-ATP; positive controls are pJP4. A nega-
tive control pBS is in the first lane. 
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Tn5 Transposon Mutagenesis 
Isolation and Characterization of Mini-Tn5 Transposons 
The mini-Tn5 system utilized in these experiments was developed by de Lorenzo 
et al. (29). The system used contains kanamydn resistance and was used to produce 
transcriptional fusions. 
AEK101 and E.coli S17-1 containing the mini-Tn5 were conjugated. Approxi-
mately 5,000 isolates that were kanamycin, rifampicin, and mercury resistant were 
isolated. These isolates were tested for the ability to metabolize TFD as a sole carbon . 
source. Of the 5,000 isolates, 30 were unable to metabolize TFD as a sole carbon 
source. 
The ability of kanamycin resistance to be conjugated to PP0300 was then studied. 
Conjugation demonstrated the transposon had inserted into the plasmid. Of the 30 
isolates unable to metabolize TFD as a sole carbon source, 27 were able to be conju-
gated to PP0300. 
The lack of metabolism of TFD and conjugation studies demonstrated these 
isolates had an insertion in p}P4. Since the isolates were unable to metabolize TFD, the 
insertions occurred in a region that was critical for growth on TFD. Induction studies 
were then performed on 15 of the isolates that were able to be conjugated. The results 
of the induction studies are shown in Table 6. The ~-galactosidase activities are charac-
teristic of three independent expression studies. 
The isolates were grouped into four categories following the ~-galactosidase 
assays. Group 1 demonstrated activities of approximately 2,000 units and an induction 
ratio of 1.00. Group 2 had induction ratios of 2.00 to 2.78 and uninduced units of about 
2,000 units. Group 3 had induced and uninduced ~-galactosidase levels of about 50 
units. The induction ratio was approximately 1.00. Group 4 had induction ratios of 
approximately 0.50. 
Five isolates were in Group 1. The ~-galactosidase activity of isolate number 1 
under noninducing conditions was 2,271 units and 2,289 units under inducing condi-
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TABLE6 
~ALACTOSIDASE INDUCTION STUDIES 
I ~alactosidase Units Induction I 
Isolate Noninduced Induced Ratio 
1 2,271 2,289 1.01 
2 1,954 2,023 1.04 
3 1,856 5,151 2.78 
4 59 61 1.03 
5 2,107 4,586 2.18 
6 1,539 1,576 1.02 
7 46 43 0.93 
8 2,297 4,569 1.99 
9 2,458 5,646 2.30 
10 1,294 1,317 1.02 
11 2,087 1,080 0.52 
12 2,019 4,707 2.33 
13 2,241 2,248 1.00 
14 2,567 5,319 2.07 
15 1,350 550 0.41 
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tions. Isolate number 2 produced 1,954 units of ~-galactosidase under noninducing 
conditions and 2,023 units under inducing conditions. Isolate number 6 had ~-
galactosidase activity that was 1,539 units under noninducing conditions and 1,576 
under inducing conditions. The ~galactosidase activity of isolate number 10 was 1~94 
units under noninducing conditions and 1,317 units under inducing conditions. Isolate 
number 13 showed ~-galactosidase activity under noninducing conditions of 2,241 and 
when grown in inducing conditions 2,248 units. These ~-galactosidase activities are 
very similar to the isolates that were inducible. 
Six isolates were in Group 2. Isolate number 3 showed almost a 3-fold induction 
rate at 2.7. This isolate showed the highest amount of induction, although the amount 
of induction was similar to the other inducible isolates. Isolates 9 and 12 showed a 
slightly lower amount of induction at 2.3-fold. Isolate number 5 had a very similar 
amount of induction at 2.2-fold. The remaining isolates, numbered 8 and 14, showed a 
2-fold rate of induction. The induction levels of all these isolates were in the same 
range. Each isolate showed noninduced P-galactosidase levels of approximately 2,200 
units. The induced level of ~-galactosidase activity for each of these isolates was 
approximately 5,000 units. The average amount of induction was approximately 2.3-
fold. 
Two isolates were in Group 3. The ~galactosidase activity was 2,087 units under 
noninducing conditions and 1,080 units under inducing conditions for isolate number 
11. Isolate number 15 produced ~galactosidase activity that was similar to number 11. 
When isolate number 15 was grown in noninducing conditions, 1,350 units were 
produced and 550 units under inducing conditions. 
Two isolates were in Group 4 .. Isolate number 4 had ~-galactosidase activity of 
only 59 units under noninducing conditions and 61 under inducing conditons. Isolate 
number 7 had similar ~-galactosidase activities as number 4. Under noninducing 
conditions, 46 units of ~-galactosidase activity were produced and 43 units under 
inducing conditions. 
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Isolates in Groups 1 and 2 had activities that were explained by the hypothesis. 
Three of the isolates were randomly selected from Grup 1 and two from Group 2; these 
were studied in greater detail. 
Detailed studies involved determining the point of insertion of the TnS trans-
poson. This was done by DNA sequence analysis. The plasmid DNA of isolates 
number 1, 2, 3, 5, and 6 were initially isolated. The isolates were then cloned into pBS. 
Each isolate was digested with BamHI and a ligation reaction set-up as described in 
Materials and Methods. The ligation mixture was transformed into DH5a . The 
transformants were selected on LB kanamycin (50 µg/ml) ampicillin (100 µg/ml). This 
would insure growth of clones that contained the mini-TnS transposon and the point of 
insertion. These plasmids could then be used in sequence analysis. 
A 17 base pair primer was used in sequence analysis. The sequence of the primer 
was taken from the 3' end of the kanamycin gene in the mini-TnS transposon. · 
Sequence data of the i:;lones are shown in Figure 5. Additional sequence data of each 
clone is not shown in this figure. Just the insertion point for mini-TnS is shown. The 
point of insertion for the mini-Tn5 fusions that were determined is shown. The 
sequence data showed where the insertion occurred. The sequence data obtained were 
aligned with sequence data for the tfd genes by the computer program MacVector 4.1. 
These alignment data were utilized to determine the position of the insertions. Figure 
6 shows alignment of the insertion point with wild type p JP4 sequences. 
Isolate number 1 had an insertion in the tf dC gene. The insertion occurred 585 
base pairs from the 5' end of the gene. Isolate number 2 had an insertion in the tfdA 
gene. The point of insertion in this gene was 250 base pairs from the 5' end of the gene. 
Isolate number 3 had an insertion in the tfdD gene. This insertion was 70 base pairs 
from the 5' end of the gene. The insertion in isolate number 5 was in the tfdE gene. 
This insertion was 65 base pairs from the 5' end of the gene. The insertion in isolate 
number 6 was in the tfdB gene. This insertion was 160 base pairs from the 5' end of the 











Figure 5. Nucleotide Sequence Data of the Clones. The underlined sequence data is the Notl site 
present in the mini-Tn5 transposon. The sequence data in bold is the O end of the 
mini-TnS transposon. The remaining sequence data are the gene in which the 
insertion has occurred. Isolate number 1 shows an insertion in the tfdC gene. 
Insertion number 2 is an insertion in the tfdA gene. Insertion 3 is in the tfdD gene. 
Insertion number 5 is in the tfdE gene and insertion 6 in the tfdB gene. 
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Isolate No. 1 
No. 1. G CCC CC G CACI I GI A I A AG AG IC AG TC T G G TC GA T GA CC GT CT CA AG ACT TAC GA 
"V" VV""V" "VV"VVVVVVV"V "VV """" """"" "" """ "V """" "" """"" """ 
~C GACCCTACTATCGCGACGACGCCCCTCTGGTCGATGACCGGCTCAAGACTTACGA 
Isolate No. 2 
No.2. GCC CCCGCACTTG TATAAGAGTCAG CGATATCGAGTT TG CCGATCTCGCCCCGGG 
V V V V V "V V V V V V" "V V V V.V V" "V" V "" " """ "A" " " "'V" " " " " "" A "" " " A I\. A I\ I\ 
~A AGAGACAGCGCCGTGCCGAGGTAGCCGATATCGAGTTGGCCGATCTCGCCCCCGG 
Isolate No. 3 
No. 3. G CCC CC G CACI I GI A I A AG AG IC AG TC ACT AC CG T G CA CC AG CA GAG CT AC GT TA 
V " " V V V V V V " V V V A V V " V V V "" "" V V " " A " " A " " A A " " " " A. " " " A " A " A A A " " " " " 
ifdD ACCAAGCGGCCGATCCAGATGTCGATCACTACCGTGCACCAGCAGAGCTACGTTA 
Isolate No. 4 
No. 4. G CCC CC G CACI I GI At A AG AG IC AG TC G C TTT GA TG CC TA ACT CG GATA G CC GA CG 
VVVVVVV"""V"VVVV VVVV "VVV" ""Al\"""""""/\. "I\"" 1\1\I\I\ """"AA/\"" I\/\ 
~E TTGAGATCACGTCGCGCTCGGGTGGTCGCTTTGGTGCCTACCTCGGAAAGCCGACG 
Isolate No. 5 
No. 5. G CCC CC G CA C II GI A I A AG AG IC AG CA AC G CA CA TTG GA CAT CC T G CG T GA TC G C 
V V V "V " V V V V " V V V " V " V V " V V V " V " " " " " " " " A V " " A A V I\ " " "'" " " " I\ " " " " A A 
~B CGACGCCGCGTGCCACATCACCAACCAACGCACAATGGAGATCCTGCGTGATCGC 
Figure 6. Sequence Alignment Data. Top sequence represents data from each of the clones; 
bottom segment represents data from wild type plasmid; underlined sequence 
data represent mini-Tn5 sequences. (Symbols: A identical sequences, V non-
identical sequences.) c.n ...... 
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Figure 7. Illustration of Mini-Tn5 Transposon Insei:tion Sites. The BamHI-B, F, E, C, and D 
fragments of pJP4 and locations of known tfd genes are shown. The open 
boxes represent position of genes; the genes are identified by the names inside 
the open boxes; the arrows represent positions of mini-Tn5 transposon 





A second insertion of Tn5 could prevent production of the inducing agent. This 
could alter the interpretation of the ~-galactosidase assays. To ensure that two 
insertions had not occurred, hybridization studies were performed. An internal 
HindIII fragment of Tn5 was used as a probe. Figure 8 represents the audioradiograph 
from the hybridization. Each pJP4 mutant was digested with BamHI and EcoRI. The 
samples are in Lanes 2 through 11. The BamHI and EcoRI digests are run next to each 
other. A single band from each isolate demonstrated that a single insertion was 
present. If a second insertion had occurred, two bands would be present in the 
audioradiograph. Positive control is present in Lane 1 and p}P4 is present in Lane 12 · 
as a negative control. The single band in each lane represents a single insertion of Tn5. 
Utilizing the sequence data and ~-galactosidase induction assay numbers, it was 
determined that the most likely inducing agent for the TFD pathway is 2,4-dichloro-
muconate. 
14.0 kb ---1.i 
6.5 kb----·· 
3 .0 kb ---1.i 
Lane 1: Positive Control 
Lane 2: Mutant 2, BamHI Digest 
Lane 3: Mutant 2, EcoRI Digest 
Lane 4: Mutant 6, BamHI Digest 
Lane 5: Mutant 6, EcoRI Digest 
Lane 6: Mutant 1, BamHI Digest 
Lane 7: Mutant 1, EcoRI Digest 
Lane 8: Mutant 3, BamHI Digest 
Lane 9: Mutant 3, EcoRI Digest 
Lane 10: Mutant 5, BamHI Digest 
Lane 11: Mutant 5, Eco RI Digest 
Lane 12: pJP4 




Gene Fusions and Transposon Mutagenesis 
Molecular genetic techniques are utilized in this study to determine the inducing 
agent of the TFD pathway. Other inducing agents for members of the LysR family of 
proteins have been discovered. The inducing agent for the benzoate pathway was 
discovered by gel shift analysis of the regulatory gene in the presence of the inducer. 
When the intermediate of the pathway such as muconate, 3-chlorocatechol, and 2-
chloromuconic can be purchased, gel shift analysis can be utilized in determining the 
inducing agent of the pathway. The inducing agent for the TFD pathway !s more 
difficult to determine. The intermediates in the pathway have short half-lives and 
cannot be purchased commercially. As a result of this, a different technique had to be 
employed to determine the inducing agent. 
A system that would enable the genes in the pathway to be assayed under 
inducing and noninducing conditions needed to be utilized. Inducing conditions were 
the presence of TFD and noninducing conditions did not contain TFD. TFD is not the 
substrate that interacts with the regulatory gene to enhance transcriptional activation. 
Each gene product has some level of constitutive expression which ensures the 
production of all metabolites when TFD is present. This allows one of the down-
stream metabolites, the inducing agent, to interact with the regulatory genes. This 
interaction results in increased transcriptional activation of the genes that the regulator 
controls. Since the intermediates cannot be purchased or easily synthesized, being able 
to assay the expression of these gene products is important for determining the 
inducing agent. A simple assay does not exist for each of the genes in the pathway. 
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Assaying for each gene product under physiological conditions is not a feasible option 
either. 
Not being able to purchase the intermediates of the pathway and not having a 
simple assay were obstacles that had to be overcome. A solution to these problems 
was producing gene fusions with a reporter gene that can be easily assayed. A 
reporter gene that is commonly used in the construction of gene fusions is the E. coli f3-
galactosidase structural gene, lacZ. The (3-galactosidase structural gene was chosen for 
gene fusions because of the wide variety of delivery mechanisms available and the ease 
of·assaying for activity. 
A delivery system had to be utilized that would allow for production of gene 
fusions. Transposons have been used in numerous studies to produce gene fusions and 
study gene organization and expression in a variety of organisms (15, 29, 101). A 
modified transposon system was the most convenient way to produce lac fusions. 
The production of lac fusions allowed the inducing agent of the TFD pathway to 
be determined. At least two regulatory genes have been identified for the TFD 
pathway (47, 56, 57). The regulatory genes are thought to have inducing activity as 
well as regulatory activity. The two proteins are members of the LysR family of 
activator proteins. Other members in this family have been shown to require effector 
molecules for activity. 
Finding the inducing agent that interacts with the regulatory genes of the TFD 
pathway is the purpose of this research. The inducing agent may interact with the 
regulator in the same way as other LysR family members. Transposon mutagenesis 
was utilized because the intermediates in the pathway cannot be purchased. The 
intermediate compounds are not synthesized commercially. 
The lacZ gene fusions were assayed under inducing and noninducing conditions. 
Under inducing conditions the expression of gene fusions occurred at two distinct 
levels depending on where the insertion occurred. Once the inducing agent of the 
pathway is produced, the genes in the pathway transcribed prior to the inducing agent 
are transcribed at an increased level. H the lacZ gene fusion inserted in a gene that is 
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transcribed before the inducing agent, the inducing agent is not produced. If the 
inducing agent is not produced, the pathway is not induced. A lack of induction was 
demonstrated by the inability of ~-galactosidase activity to be increased under 
inducing conditions. Any gene fusion not induced when grown in the presence of TFD 
occurred before the production of the inducing agent. If an increase in ~-galactosidase 
activity results when the insertion mutant is grown in the presence of TFD, the inducing 
agent was produced. The inducing agent was able to interact with the regulator gene 
and induce the pathway. Increased expression of the pathway is a result of induction. 
By utilizing a combination of noninducible and inducible transposon mutants, the 
inducing agent was determined. 
Tn3 Transposon Mutagenesis 
The Tn3 lacZ transposon was developed to produce random insertions of lac 
fusions useful in the study of gene organization and expression. Tn3 is able to 
transpose at a high frequency into plasmid DNA versus chromosomal DNA, generates 
both transcriptional and translational hybrid lacZ gene fusions and can be stable after 
transposition by supplying transposase activity in trans. 
The lacZ coding sequences within Tn3-HoHol are open and in-frame to the end of 
the Tn3 left terminal repeat. When Tn3-HoHol inserts into a gene so that the coding 
sequences of the gene are in-frame to the lacZ coding sequences, expression of the gene 
will result in the production of a hybrid ~-galactosidase protein. If the coding 
sequences are not in-frame following an insertion, a nonhybrid 13-galactosidase protein 
will be the result of gene expression. Translation will be initiated within the 
transposon lacZ sequences. Six methionine codons occur in frame 5' of the lacZ struc-
tural gene. Translation can be initiated at one or more of these codons if transcription 
occurs across this region (101). Transcriptional control sequences do not precede the 
lac sequences within Tn3. The production of ~-galactosidase is dependent on expres-
sion that initiates outside of and reads into the element. 
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Tn3-HoHol is defective for transposase activity. To allow Tn3-HoHol trans-
position, pSShe was constructed to supply tnpA activity in trans. The pSShe plasmid 
encodes transposase activity but cannot be transposed. 
These properties of the Tn3-HoHol system made it appear suitable for the 
production of lac fusions into the plasmid p}P4. The plasmid pJP4 was able to be 
maintained in the same environment as the pHoHol and pSShe plasmids. Since p}P4 
was able to be maintained in the same bacteria as the pHoHol and pSShe plasmids, it 
would seem that transposition to pJP4 would occur at a rate that could be detected. 
The antibiotic resistance marker ampicillin was able to be conjugated from the 
HB101 strain to the SF800 strain. This shows that the Tn3 transposon could be trans-
posed into the pJP4 plasmid. When the plasmid pJP4 was conjugated into A . 
. eutrophus, the ability to grow on TFD as a sole carbon source was detected. Using 
TFD as selection it would be easy to determine if an insertion in the pathway had 
occurred. If an isolate was unable to grow, then the pathway must have been inter-
rupted by a transposon insertion. Subsequent analysis would then be used to 
determine where the insertion had occurred. 
None of the isolates that were picked were unable to metabolize TFD as a sole 
source of carbon. Using the modified Tn3 transposon, no isolates were able to be 
identified that were blocked in the TFD pathway. A large number of isolates were 
tested, so this should not have been a factor. 
Some aspect of the plasmid p}P4 could be preventing the appropriate insertions of 
the Tn3-pHoHo 1 plasmid. Studies have been produced that show clustering of Tn3 at 
certain DNA locations is determined by the nucleotide sequence of the recipient 
genome (17). Analysis of insertions showed the presence of several distinct hotspots. 
Determinination of the DNA sequence in the vicinty of the hotspot region for Tn3 
insertion indicated that a major homology with a sequence within Tn3 existed. A 
regional specificity of Tn3 insertion with a strong preference for AT-rich segments has 
been proposed (63). The site of insertion of Tn3 is partially determined by the primary 
nucleotide sequence of the recipient genome. 
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These transpositional facts about Tn3 suggest a possible reason why no insertions 
were isolated in the TFD pathway. It may be possible that hotspots exist in the pJP4 
plasmid. The hotspots could be the point where insertions have occurred. These 
hotspots would not be in any genes of the TFD pathway since growth was not 
interrupted. The entire sequence of pJP4 is not known. This does not allow any 
possible sequences to be identified from the sequence data. The insertion sequence 
was not determined for any of the transposon mutants. It was not determined if any 
hotspots are present in pJP4. 
From these experiments it does appear that Tn3 is not a suitable transposon for 
the production of the desirable mutants. The transposon was not able to insert into 
any regions of interest in pJP4. As a result of these two observations, another sytem 
was used to produce gene fusions. 
Bacteriophage Mu Transposition 
Although Mu is actually a bacteriophage, movement of the phage is similar to a 
transpositional event by a transposon. Several properties of bacteriophage Mu have 
made it useful for genetic manipulations (13, 52, 105). Mu is a temperate phage which 
replicates by a process that involves DNA transposition. Transposition to new sites 
can be induced at a high rate by lytic growth, or it can be repressed in the lysogenic 
state. Mu has a headful mechanism for packaging its DNA. A total of approximately 
38 kb including the Mu genome can be taken up into a viral particle and carried to a 
new cell upon infection (14). New DNA sequences can be incorporated between the 
ends of the Mu genome and carried as part of the phage genome. Segments of the Mu 
genome can be removed without affecting phage growth or intracellular transposition. 
These functions can be complemented by a nondefective helper Mu phage as long as 
the DNA sequences at each Mu end are maintained (104). 
Modified Mu phages have been constructed that allow for the production of lac 
fusions. The properties of bacteriophage Mu allowed the construction of the mini-Mu 
60 
phage used in these studies. The mini-Mu system used in these studies was developed 
by Castillio et al. (15) and contains a selectable drug resistance gene, kanamycin. The 
mini-Mu phage is also missing the transposition genes necessary for movement and the 
packaging genes used in the life cycle. These functions are supplied in trans by 
insertion of a temperature-sensitive Mu phage in the chromosome. Insertions following 
the initial transposition are genetically stable and incapable of subsequent trans-
position. These elements permit the use of the Mu transduction process to select Mu 
insertions, including insertions in high copy-number plasmids. 
Using mini-Mu phages for the production of lac fusions requires a different scheme 
than using a transposon such as Tn3 or Tn5. The mini-Mu system is unable to package 
the entire p}P4 plasmid. The transposition of mini-Mu cannot be used with p}P4. To 
overcome this situation portions of p}P4 were subcloned. The fusions were produced 
in a region of pJP4 that was thought to contain the gene that coded for the enzymes 
responsible for the production of the inducing agent. This region was small enough, 2.5 
kb, so that the insertion could be easily mapped. 
Introduction into p}P4 was attempted by a homologous recombination event. This 
event allowed the introduction of the fusion gene into pJP4. Several different 
techniques were employed to induce the recombinational event involving A. eutrophus 
and E. coli strains. In contrast to some other bacteria, E. coli is not able to be 
transformed by linear pieces of DNA (98). No references were found about possible 
linear transformation of A. eutrophus. 
The inability to take up linear DNA by E. coli is due in part to degradation of the 
incoming DNA by intracellular exonucleases (51). E. coli strains lacking exonuclease V 
by virtue of recB or recC mutations can be transformed by linear DNA if they carry the 
sbcB and sbcC mutations that as well restore recombination proficiency to the recB recC 
mutant. A recD mutant also lacking exonuclease activity can be transformed with 
linear DNA. Since these stains have been reported to be useful for linear trans-
formation, they were utilized in these studies. 
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The initial plasmids that were produced contained the same pattern on an agarose 
gel as wild-type pJP4 and showed no hybridization with any portion of the mini-Mu 
phage. These were produced by linearizing the fragment with a single restriction 
enzyme. The remaining pBS tfdDEF mini-Mu fusion mutants did produce a recom-
. . 
binational event. These linear fragments were produced by digesting with two 
restriction enzymes and separating the vector DNA from the mini-Mu and cloned 
DNA. The recombination event did not replace the desired fragment in pJP4 but 
appeared to produce a deletion of pJP4. The tfdDEF genes that are present in the 
clone are contained in the Hindill-C fragment of pJP4. The recombination event that 
occurred resulted in a large deletion of pJP4. A HindIIl digest of these fusion mutants 
results in a band at 18 kb on an agarose gel. The size of this band is between HindID 
fragments B and C of pJP4. The pJP4 Hindill-B and C fragments are not present in 
these mini-Mu fusion mutants. The mini-Mu fusion plasmids have lost approximately 
15 kb of DNA. 
A second copy of the tfdD gene is present in the Hindlll-B fragment (70). The 
distance between the second copy of tfdD and the tfdD gene in the tfdCDEF operon is 
approximately 15 kb: The removal of this fragment results in the loss of three HindIII 
restriction sites. If these sites were lost, the Hindill-B and C fragments would become 
one fragment. The restriction sites that are lost produce the B and C fragments from a 
Hindill restriction digest. The loss of these sites would produce a fragment that is 
approximately 18 kb. From the Southern hybridizations it was shown that the 18 kb 
fragment did hybridize to the tfdDEF fragment in a probe. The possible position of the 
mini-Mu phage in the deleted plasmids was not determined. 
It appeared from the restriction digest and Southern hybridizations that a large 
deletion has occurred. If the deletion occurred between the two tfdD genes, it may be 
possible that a recombinational event occurred as a result of possible homology 
between the two genes. A looping out of the DNA segment between the two genes may 
have occurred. The Southern hybridization does not prove that the deletion occurred 
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as described, but it does offer a possible suggestion of the event that did occur. 
Further hybridization studies using the mini-Mu phage and possible missing sequences 
as a probe could give more evidence to support the possible recombination event. 
When fusions of pBS tfdDEF were analyzed, a pattern of insertions developed. 
These isolates had an unusually high insertion rate in an· 888 bp region of the pBS 
tfdDEF. Ideally for the most efficient homologous recombination to occur, at least 200 
bp of homologous DNA should exist on each side of the fusion. Further analysis of 
these isolates in the 888 bp region showed that the insertion was within 250 bp of the 
fragment end. It was possible that a hotspot for mini-Mu. phage existed in this region. 
Some insertions have been shown to occur in the same location by recombination tests 
(15). Experiments have shown that a shortened version of the pBR322 plasmid had 
hotspots for insertion (15). The insertions in the pBS tfdDEF clone could be very close 
to the end of the fragment. This could be preventing a homologous recombination 
event from occurring. 
From these studies it appeared that a mini-Mu phage system was not adequate 
for producing lac fusions in areas of interest. The mini-Mu phage was able to 
transpose into the tfdDEF region that had been cloned. From a rough screening of the 
isolates it appeared that a possible hot spot for insertion was present in this small 
region. This region must have been close to the end of the tfdDEF sequence that was 
cloned. A recombination event was not able to be produced. When a recombination 
event did occur, the result appeared to be a large deletion. 
The mini-Mu phage was useful in the production of insertions. Limitations seem 
to have occurred in the homologous recombination event. The production of a 
homologous rcombination event was difficult to produce in this system. As a result of 




The Tn5 transposon has proven to be of great utility for the insertion mutagenesis 
of a variety of gram-negative bacteria (8, 60, 71, 96, 97). A variety of mini-Tn5 deriva-
tives have been constructed for generating gene and operon fusions (29). The mini-Tn5 
utilized in these experiments has a promotorless trp'-'lacZ fusion with its Shine-
Dalgarno sequence downstream of the Tn5 I end of the transposon to generate operon 
fusions. The mini-Tn5 utilized in these experiments has a promoter-less trp'-'lacZ 
fusion with its Shine-Dalgarno sequence downstream of the Tn5 I end of the trans-
poson to generate operon fusions. The fusions begin with a 'lacZ moeity at codon 9, 
which is separated from the interrupted gene by a 49-base-pair linker sequence 
composed of the 19-base-pair I end of Tn5 and an additional 30 base pairs resulting 
from different steps in the construction (29). The creators of this system suggest that it 
is much simpler to use for the creation of transcriptional fusions than Tn3, other Tn5 
systems, and Mu phage constructs (29). 
Using the mini-TnS system a large number of insertions were produced. These 
were screened and a small portion of these were found to be in pJP4. The simplest 
way to determine if the TFD pathway has been interrupted is to test for growth on 
TFD as a sole carbon source. If the isolate is unable to grow on TFD, the pathway 
must have been interrupted. The isolates that were unable to grow on TFD were 
analyzed for the ability to conjugate the kanamycin resistance of mini-Tn5. If the 
marker can be conjugated, the insertion must have occurred on pJP4. It would be 
possible to produce insertions in the chromosome that would inhibit growth on TFD. 
Isolates that were unable to grow on TFD and kanamycin resistance could be 
conjugated were analyzed for !3-galactosidase activity. 
The 13-galactosidase activity of a number of these was determined. Several 
different types of induction patterns resulted when expression assays were performed. 
It was expected that a certain constitutive level of expression would occur for each of 
the fusions. An uninduced level of protein product is present even when no TFD is 
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present. When TFD was present, it was expected that a number of the isolates would 
show some level of increase in ~-galactosidase activity. This would mean that the 
inducing agent had been produced and increased activation of the pathway had 
occurred. Eleven isolates showed ~-galactosidase activity that fit the hypothesis. The 
levels under noninducing conditions were similar and six of these showed increased 
levels of induction in the presence of TFD. 
Detailed studies of Groups 1 and 2 involved determining where the point of 
insertion of the trans-poson had occurred. This was done by sequence analysis. In 
order to sequence these constructs a primer had to be developed that would allow the 
end of the transposon into the insertion point to be sequenced. The sequence of the 
gene that is responsible for resistance to kanamycin has been determined (77). A 
primer for sequencing was able to be created from the sequence data. The primer 
hybridized to the 3' end of the gene. This allowed sequencing through the end of the 
kanamycin gene, to the end of the transposon, through the point of insertion, and into 
the gene where insertion had occurred. Identifying the point of insertion was the data 
needed from these sequences. These sequence data were then aligned with sequence 
data that had been produced for the TFD pathway. The three operons of the pathway 
have been completely sequenced. 
In order to get sequence data of the insertions it was necessary to isolate the 
plasmid DNA. The plasmid pJP4 is a very large plasmid and difficult to isolate. It 
was very difficult to isolate a significant quantity of highly purified and concentrated 
DNA for sequencing. As a result of this the point of insertion needed to be cloned into 
a high copy number vector. This allowed for a high concentration of highly purified 
DNA to be isolated and sequenced. By selecting for kanamycin resistance it was easy 
to directly select for clones that contained the mini-Tn5 transposon and the point of 
insertion. A single BamHI site was present at the 5' end of the transposon. This 
allowed virtually the entire mini-Tn5 transposon to be cloned. The restriction pattern 
of pJP4 when digested with BamHI was also known. From these sites, it could be 
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determined that the largest fragment that would be produced, if the mini-TnS had 
inserted into one of the genes of the pathway, was approximately 5 kb. The mini-TnS 
was approximately 5 kb. The largest fragment that would be cloned would be 
approximately 10 kb. This size fragment could be cloned into a high copy number 
vector such as pBS. 
The plasmids of five of the isolates from Groups 1 and 2 were isolated and 
attempts were made to clone the desired region. Clones from these five isolates were 
produced and sequenced. The sequence data were analyzed and the point of insertion 
determined. From these data the inducing agent of the pathway was determined. Of 
the isolates that were sequenced, three were noninducible and two were inducible. The 
isolates that were inducible must have inserted into genes that are transcribed after the 
inducing agent is produced. The noninducible isolates must have insertions in genes 
that are transcribed before the production of the inducer. 
If a second copy of the transposon did insert in pJP4, the analysis of the 13-
galactosidase assays would be different. If two insertions occurred in isolate 1, and 
the second insertion was in fdc, removal of the insertion could allow production of the 
inducing agent. The second insertion would have resulted in an inappropriate 
identification of the inducing agent. A Southern analysis was performed to determine 
how many copies of TnS were present in pJP4. Figure 8 shows that only one copy of 
TnS is present in pJP4. If a second copy was present, two bands would have been 
produced on the audioradiograph. The second insertion would cause a change in the 
restriction pattern, producing two bands. The single band demonstrates that only one 
insertion of TnS has occurred. 
The noninducing isolates were in the tfdA, tfdB, and tfdC genes. The inducing 
agent of the pathway must be a product that is produced after the tfdC gene is 
transcribed. A lack of induction showed that the inducing agent had not been 
produced. The products after the tf dC gene in the pathway are 2,4-clichloromuconate, 
2-chlorodiene lactone, and chloromaleylacetic acid. One of these products must be the 
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inducing agent of the pathway. The isolates that showed induction in the presence of 
TFD were found to be inserted in the tfdD and tfdE genes. The inducing agent was 
produced and the result was an increased j>,galactosidase activity. 
The gene product of tfdC produces 2,4-dichloromuconate from 3,5-dichloro-
catechol. When the dichloromuconate is not produced, the pathway is not induced. 
This is shown by the tfdC insertion mutant. The pathway has been blocked before the 
inducing agent is produced. 13-Galactosidase activity is not increased because the 
inducing agent was not produced. The two insertions that have occurred in the tfdA 
and tfdB genes have also blocked the pathway before the inducing is produced. 
When an insertion has occurred in the tfdD gene, a new pattern of 13-galactosidase 
activity is produced. When this mutant is grown under inducing conditions, the 
amount of 13-galactosidase activity that is produced is more than double the 13-
galactosidase activity that is produced when the mutant is grown under noninducing 
conditions. The pathway in this mutant must be blocked after the inducing agent is 
produced. This would explain the increased production of 13-galactosidase activity 
under inducing conditions. The gene product of tfdD converts dichloromuconate to 
chlorodiene lactone: The inducing agent was produced in this mutant. The last 
product that is produced by this mutant is chlorodiene lactone. The inducing agent 
must be a product in the pathway that precedes chlorodiene lactone. 
From the tfdC mutant it was shown that the inducing agent must be a product that 
is produced after the dichlorocatechol. With the information from the tfdD mutant, 
that the inducing agent must be produced before the chlorodiene lactone, the inducing 
agent of the pathway can be determined. The product that is produced immediately 
after the dichlorocatechol and before the chlorodiene lactone is dichloromuconate. The 
dichloromuconate is not produced by the tfdC mutant, but is produced by the tfdD 
mutant. The dichloromuconate is the product that is produced by the tfdD mutant 
that allows induction of the pathway. The lack of production of this product in the 
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tfdC mutant prevents the induction of the pathway. The chloromuconate is most likely 
the inducing agent of the pathway. 
Isolates in Groups 3 and 4 had J>-galactosidase activities that were different than 
Groups 1 and 2. A possible reason could be that an insertion in a regulatory gene 
could have occurred. The expression levels of the regulatory genes may be different 
than the structural genes. This could explain the expression levels characteristic of 
Group 3. An insertion in the carboxy-terminal region of a regulatory gene could explain 
the expression patterns in Group 4. An insertion could have occurred that allowed 
binding of the regulator, such as Tfd.R, to the promoter region, but would not allow 
transcriptional activation of the operon. This would result in less expression when 
TFD is present. In the presence of TFD down regulation of the regulator would occur. 
Group 4 shows less expression in the presence of TFD. 
The fact that the chloromuconate is the inducing agent of the pathway is not a 
complete surprise. The inducing agent for the degradation of benzoate was found to 
be muconate. Benzoate is converted to ~-ketoadipate with catechol being an 
intermediate. Catechol is converted to muconate and then to muconolactone. The 
conversion occurs by the catB and catC gene products. The protein CatR is an 
activator of the catechol degradation genes catBC. This pathway is similar to the 
TFD. The products of pathway are identical except for the fact that the products are 
chlorinated in the TFD pathway. The regulatory proteins CatR and TfdR are very 
similar (70). These are similar pathways and the inducing agent of the catBC operon 
has been shown to be muconate. 
The fact that a muconate derivative is the inducing agent for the TFD and CAT 
pathways suggests that the TFD pathway may have evolved from the CAT pathway. 
The TFD pathway may have evolved from the catechol pathway after the chlorinated 
compound entered the environment. When TFD was introduced into the environment, 
random mutation of genes would result in genes that would encode for the metabolism 
of a chlorinated product. If muconate had evolved as a regulatory mechanism, it 
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would be likely that it would continue to be utilized in the same manner. A new 
inducing agent would not be selected, but the mutation of an inducing agent that 
existed. This would result in similar regulatory mechanisms. Benzenoid residues such 
as those found in lignin are among the most common units encountered in nature (36). 
The conversion of benzoate to ~-ketocadipate is widely distributed and may have 
served as a starting point for the evolution of chlorinated aromatic pathways. 
The chloromuconate of other pathways similar to the TFD pathway has also been 
suggested to be the inducing agent. In these pathways the inducing agent has been 
speculated to be a chloromuconate intermediate in the pathway. With all these 
pathways being very similar, the inducing agent in each of these pathways may also be 
very similar. The work produced in these studies does suggest that the inducing agent 
of each pathway may be the chloromuconate intermediate of the pathway. 
The nature of the specific activation mechanism is not understood. Under-
standing the nature of inducer-activator interactions, and the role they play in trans-
criptional activation, will help in the engineering of biodegradative pathways for 
compounds that currently cannot be degraded by bacteria. 
The mini-TnS transposon was a very useful tool for genetic studies using A. 
eutrophus. With this system lacZ gene fusions were produced in genes of the TFD 
pathway. With the other systems used in these studies no usable gene fusions were 
obtained. The mini-TnS transposon system was the only system that was able to be 
used successfully. With this system the inducing agent of the pathway was 
determined. 
Sequence analysis has shown that several different pathways involved in the 
metabolism of chlorinated aromatics are very similar. The structural and regulatory 
genes have shown sequence similarity and the regulatory patterns of the pathways 
appear to be similar (26, 70, 107). These pathways include TFD, CAT, TCB, and CLC. 
The data presented here have shown that the most likely inducing agent of the 
TFD pathway is the chlorinated muconate intermediate of the pathway. Since this 
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pathway is similar to other chlorinated aromatic degrading pathways discussed 
above, it is also possible that the chlorinated muconate intermediate found in these 
pathways are the inducing agents. If the inducing agents for all of these pathways are 
found to be chlorinated muconates, the importa.nce of these compounds in the 
regulatory scheme of these pathways will be shown. 
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